FGEN


Line plots across dimensions of each concept
Line plots across concepts
Tables

Table of contents



us-gaap:CommonStockValue

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeTaxExpenseBenefit

us-gaap:InterestExpense

us-gaap:InterestIncomeExpenseNonoperatingNet

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:OperatingExpenses

us-gaap:OperatingIncomeLoss

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossNetOfTax

us-gaap:ProfitLoss

us-gaap:ResearchAndDevelopmentExpense

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:BalanceSheetLocation, us-gaap:ValuationAllowancesAndReservesType
us-gaap:ProductOrService
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:ProductOrService, us-gaap:ValuationAllowancesAndReservesType
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:TransactionType, us-gaap:ValuationAllowancesAndReservesType
us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:ValuationAllowancesAndReservesType

us-gaap:Revenues

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:Assets

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity

us-gaap:AssetsCurrent

us-gaap:Cash

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:GeographicDistribution

us-gaap:ShortTermInvestments

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet
us-gaap:StatementGeographical

us-gaap:InventoryFinishedGoods

us-gaap:OtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:PropertyPlantAndEquipmentNet
us-gaap:StatementGeographical

us-gaap:LongTermInvestments

us-gaap:OperatingLeaseRightOfUseAsset
us-gaap:AdjustmentsForNewAccountingPronouncements
us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:StatementGeographical

us-gaap:OtherAssetsNoncurrent

us-gaap:AccountsPayableCurrent

us-gaap:AccruedLiabilitiesCurrent

us-gaap:ContractWithCustomerLiabilityCurrent
us-gaap:StatementGeographical, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:ValuationAllowancesAndReservesType

us-gaap:LiabilitiesCurrent

us-gaap:OperatingLeaseLiabilityCurrent
us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent
us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:OperatingLeaseLiability
us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:StockholdersEquity

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapital

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInInventories

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:ProfitLoss

us-gaap:ShareBasedCompensation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:DeferredTaxLiabilities

us-gaap:DeferredTaxAssetsNet

us-gaap:UnrecognizedTaxBenefits
us-gaap:IncomeTaxAuthority

us-gaap:DeferredTaxAssetsValuationAllowance

fgen:AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid
us-gaap:StatementEquityComponents
us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement
fgen:CoPromotionExpenses
us-gaap:TypeOfArrangement
fgen:CollaborationServicesAndOtherRevenue
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:SubsequentEventType
fgen:CommercialMilestone
us-gaap:ProductOrService
fgen:ContractWithCustomerLiabilityAdditions
us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement
us-gaap:ProductOrService
fgen:ContractWithCustomerLiabilityDeduction
us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
us-gaap:ProductOrService
fgen:ContractWithCustomerLiabilityIncreaseDecreaseFromCurrentTranslationAndOther
us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

fgen:CostOfGoodsAndServicesSoldOperatingExpense
us-gaap:RelatedPartyTransactionsByRelatedParty
fgen:DrugProductRevenueFromRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TransactionType
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement
us-gaap:EquityMethodInvestmentNonconsolidatedInvestee
fgen:EquityMethodInvestmentIncreaseDecreaseFromCurrencyTranslation
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:SubsequentEventType
fgen:FutureManufacturingClinicalRegulatoryAndCommercialMilestonePayments

fgen:IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities

fgen:IncreaseDecreaseInRevenueDueToOutOfPeriodAdjustments
us-gaap:TypeOfArrangement
fgen:InitialUpfrontPayment
us-gaap:TypeOfArrangement
fgen:InterestAndOtherIncomeFromRelatedParty

fgen:InterestIncomeAndOtherIncomeExpensesNet

fgen:InvestmentLossInUnconsolidatedVariableInterestEntity
us-gaap:TypeOfArrangement
fgen:LicenseFeesAndMilestonesRevenue
us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased
fgen:MaximumFutureMilestonePayments

fgen:PaymentsToAcquireAvailableForSaleSecuritiesAndTermDeposit
us-gaap:BusinessAcquisition, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty
fgen:PercentageOfOutstandingSharesOfAcquireeSoldByAcquirer
us-gaap:BusinessAcquisition, us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
fgen:PotentialMilestones
us-gaap:TypeOfArrangement
fgen:ProductRevenue

fgen:RepaymentsOfFinanceLeaseLiabilities
us-gaap:ProductOrService
fgen:RevenueGrossFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
fgen:RevenueGrossTransferPriceFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
fgen:ReversalOfPreviouslyAccruedLongTermCoPromotionExpenses

fgen:UnconsolidatedVariableInterestEntityInvestmentIncome

fgen:UnconsolidatedVariableInterestEntityInvestmentLoss

fgen:UnrealizedLossGainOnEquityInvestments
us-gaap:StatementGeographical
fgen:VariableConsiderationPaymentReceivedFromEstimatedFutureCoDevelopmentBilling

us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments

us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
us-gaap:BusinessAcquisition, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:BusinessCombinationAcquisitionRelatedCosts
us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:BusinessCombinationConsiderationTransferred1
us-gaap:TypeOfArrangement
us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
us-gaap:TypeOfArrangement
us-gaap:ContractWithCustomerLiabilityRevenueRecognized

us-gaap:Depreciation

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
us-gaap:BusinessAcquisition, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:EquityMethodInvestmentSoldCarryingAmount
us-gaap:BusinessAcquisition, us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:FinanceLeaseInterestExpense

us-gaap:FinanceLeaseInterestPaymentOnLiability

us-gaap:FinanceLeaseRightOfUseAssetAmortization

us-gaap:GainLossOnDispositionOfAssets
us-gaap:EquityMethodInvestmentNonconsolidatedInvestee
us-gaap:IncomeLossFromEquityMethodInvestments
us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities

us-gaap:IncreaseDecreaseInOtherOperatingAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:InterestAndOtherIncome
us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:InvestmentIncomeNet

us-gaap:LeaseCost

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeasePayments

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation

us-gaap:PaymentsToAcquireAvailableForSaleSecurities

us-gaap:PaymentsToAcquireBusinessesGross
us-gaap:BusinessAcquisition, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:ProceedsFromIssuanceOfCommonStock

us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
us-gaap:SubsequentEventType
us-gaap:ProceedsFromSaleOfEquityMethodInvestments
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty

us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TransactionType
us-gaap:RevenueFromRelatedParties
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:SubleaseIncome
us-gaap:BusinessAcquisition, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:VariableInterestEntityOwnershipPercentage
us-gaap:BusinessAcquisition, us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment

fgen:AccruedActivePharmaceuticalIngredientProductPriceAdjustmentCurrent

fgen:AccruedCoPromotionExpensesCurrent

fgen:AccruedContractLiabilitiesToPharmaceuticalDistributorsCurrent

fgen:AccruedLongTermCoPromotionLiabilityCurrent
us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement

fgen:AccruedLongTermCoPromotionLiabilityNonCurrent
us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
fgen:AccruedLongTermCoPromotionalLiabilityNonCurrent
us-gaap:StatementScenario, us-gaap:TypeOfArrangement

fgen:AccruedPreclinicalAndClinicalTrialCurrent

fgen:AccruedProductDevelopmentCosts

fgen:AccruedProductDevelopmentCostsExcludingInterest

fgen:AvailableForSaleSecuritiesBondAndMutualFundsMaturingWithinOneYear
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
fgen:CashConsiderationReceivedUnderCollaborationAgreement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
fgen:CollaborativeArrangementAggregateConsideration
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:SubsequentEventType
fgen:CollaborativeArrangementAggregateConsiderationForMilestoneAndUpfrontPayments

fgen:CommonStockSharesReserved
us-gaap:ProductOrService
fgen:ContractWithCustomerLiabilityGross
us-gaap:ProductOrService
fgen:ContractWithCustomerLiabilityNetOfAccountsReceivable

fgen:CorporateBondsAtCarryingValue
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
fgen:CumulativeRevenueLicenseAndDevelopmentRevenueRecognized
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:DeferredTaxAssetsIntangibleAssets

fgen:DeferredTaxLiabilitiesFixedAssets

fgen:DueToRelatedPartiesDeferredRevenueCurrent

fgen:DueToRelatedPartiesDeferredRevenueNoncurrent

fgen:EquityMethodInvestmentInUnconsolidatedVariableInterestEntity

fgen:FinanceLeaseAccumulatedAmortization

fgen:FinanceLeaseAndOperatingLeaseAssets

fgen:FinanceLeaseAndOperatingLeaseLiability

fgen:FinanceLeaseRightOfUseAssetsCost

fgen:LeaseObligationsNoncurrent

fgen:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
us-gaap:RelatedPartyTransactionsByRelatedParty
fgen:MiscellaneousReceivables

fgen:OperatingLeaseAccumulatedAmortization

fgen:OperatingLeaseRightOfUseAssetsCost

fgen:PercentageOfPreLaunchInventoryCapitalizedOfAggregateInventoryBalance

fgen:PropertyTaxesAndOtherCurrent

fgen:RestrictedTimeDepositsNoncurrent
us-gaap:TypeOfArrangement
fgen:RoyaltyRateOnNetRevenue

fgen:SuppliesNet
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
fgen:TransactionPriceAllocatedToPerformanceObligations

us-gaap:AccountsPayableRelatedPartiesCurrent

us-gaap:AccountsReceivableRelatedPartiesCurrent
us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

us-gaap:AccruedLiabilitiesAndOtherLiabilities

us-gaap:AccruedProfessionalFeesCurrent
us-gaap:ProductOrService
us-gaap:AllowanceForDoubtfulAccountsReceivable
us-gaap:ProductOrService, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee
us-gaap:ProductOrService, us-gaap:ValuationAllowancesAndReservesType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency

us-gaap:AvailableForSaleSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:InvestmentType

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
us-gaap:InvestmentType

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
us-gaap:InvestmentType

us-gaap:AvailableForSaleSecuritiesAmortizedCost
us-gaap:InvestmentType

us-gaap:AvailableForSaleSecuritiesEquitySecurities
us-gaap:BusinessAcquisition, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:Capital
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:CashAndCashEquivalentsFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:CommercialPaperAtCarryingValue
us-gaap:SubsidiarySaleOfStock
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

us-gaap:ContractWithCustomerLiability
us-gaap:ProductOrService
us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerLiabilityNoncurrent
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

us-gaap:ContractualObligation
us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent

us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory

us-gaap:DeferredTaxAssetsDeferredIncome

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
us-gaap:IncomeTaxAuthority

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign
us-gaap:IncomeTaxAuthority

us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
us-gaap:IncomeTaxAuthority
us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther
us-gaap:StatementGeographical, us-gaap:IncomeTaxAuthority

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent

us-gaap:DueFromRelatedPartiesCurrent

us-gaap:DueFromRelatedPartiesNoncurrent
us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:DueToRelatedPartiesCurrent
us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

us-gaap:EmployeeRelatedLiabilitiesCurrent
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
us-gaap:EquityMethodInvestmentNonconsolidatedInvestee
us-gaap:EquityMethodInvestments
us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities
us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:FinanceLeaseLiability
us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:FinanceLeaseLiabilityCurrent
us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:FinanceLeaseLiabilityNoncurrent
us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:FinanceLeaseLiabilityPaymentsDue

us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree

us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo

us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount

us-gaap:FinanceLeaseRightOfUseAsset
us-gaap:AdjustmentsForNewAccountingPronouncements
us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:StatementGeographical

us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent

us-gaap:InterestPayableCurrentAndNoncurrent

us-gaap:InventoryRawMaterials

us-gaap:InventoryWorkInProcess

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:LiabilitiesFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByLiabilityClass
us-gaap:FairValueByLiabilityClass

us-gaap:MoneyMarketFundsAtCarryingValue

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent

us-gaap:OtherSundryLiabilitiesNoncurrent

us-gaap:PrepaidExpenseCurrent

us-gaap:RecordedUnconditionalPurchaseObligation
us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear
us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear
us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased
us-gaap:BalanceSheetLocation, us-gaap:RelatedPartyTransaction
us-gaap:RelatedPartyTransactionDueFromToRelatedParty
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
us-gaap:RevenueRemainingPerformanceObligation
us-gaap:TypeOfArrangement

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
us-gaap:AwardType
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap:PlanName

us-gaap:Supplies
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TransactionType

us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
us-gaap:ValuationAllowancesAndReservesType
us-gaap:ValuationAllowancesAndReservesBalance

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Expenses
Income Tax Expense Benefit
Balance Sheet
Operating Lease Right Of Use Asset
Assets
Inventory Net
Current Assets
Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Shares Outstanding Basic
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
InventoryNet
Inventory Finished Goods

Tables

  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:CommonStockValue ████▇▇▇▇▇▇▆▆▆▆▆▆▃▂▂▂▂▂▂▁▁▁▁0.9260.9210.9140.9090.9020.8890.8770.8720.8680.8610.8540.8480.8420.8340.8250.8180.710.6440.6370.6310.6270.6240.620.6120.6040.5930.59NANANA
us-gaap:CommonStockSharesIssued █████▇▇▇▇▇▇▆▆▆▆▆▃▂▂▂▂▂▂▁▁▁▁92.60992.0891.44190.88590.22888.89687.65787.21186.84786.1385.43284.84784.18383.42182.49881.81470.96964.42263.66563.07562.74262.42561.98561.2460.3759.26859.046NANANA
us-gaap:CommonStockSharesOutstanding █████▇▇▇▇▇▇▆▆▆▆▆▃▂▂▂▂▂▂▁▁▁▁92.60992.0891.44190.88590.22888.89687.65787.21186.84786.1385.43284.84784.18383.42182.49881.81470.96964.42263.66563.07562.74262.42561.98561.2460.3759.26859.046NANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding NANANA93.67889.451NANA87.00791.728NANA84.50883.75NANANA69.638NANANA69.022NANANA68.752NANANA37.106NA
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic NANANA90.55889.451NANA87.00786.445NANA84.50883.75NANANA69.638NANANA62.582NANANA59.798NANANA13.347NA
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted █▁92.27691.688NANA89.45188.219NANANA85.704NA84.50883.7582.863NA75.89169.63864.037NA62.858NA62.184NA60.767NA59.197NA13.503NA13.21
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount █▁11.47.8NA4.29.28.7NA9.24.49.5NA9.38.8NANANANANANANA6.6NANA15.03.816.552NA48.018.646.11
us-gaap:EarningsPerShareBasic NANANA0.36-0.95NANA-0.571.34NANA-0.5-0.28NANANA-0.48NANANA0.39NANANA0.95NANANA1.36NA
us-gaap:EarningsPerShareDiluted NANANA0.35-0.95NANA-0.571.26NANA-0.5-0.28NANANA-0.48NANANA0.35NANANA0.83NANANA0.58NA
us-gaap:EarningsPerShareBasicAndDiluted ▁█-1.45-0.78NANA-0.95-0.89NANANA-0.530.25-0.5-0.28-0.5-0.24-0.5-0.46-0.52-0.54-0.38NA-0.45-0.85-0.74NA-0.78-2.5-2.93NA-1.23
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:AllocatedShareBasedCompensationExpense ███▇▇▇▇▆▇▇▆▆▅▅▄▄▄▄▄▄▄▃▃▃▃▃▄▄▁▁19.00119.38420.26917.89117.64416.91617.40214.79317.64216.4313.7114.32313.23110.8789.9319.6289.5718.4097.8768.5128.4047.347.4496.8446.9426.4468.9648.2690.670.795
us-gaap:ComprehensiveIncomeNetOfTax ▁▃▃▆▂▃▂▃█▃▅▄▄▄▄▄▄▄▄▄▅▄▃▃▆▄▃▄▆▄-133.931-71.88-58.87730.309-88.057-76.418-98.646-49.201116.478-44.67821.242-42.515-22.409-41.973-22.308-37.959-33.549-33.221-33.629-24.46324.996-27.894-51.406-46.08957.17-43.956-50.532-38.57946.736-16.77
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest ▁▃▃▆▂▃▂▃█▃▅▄▄▄▄▄▄▄▄▄▅▄▃▃▆▃▃▄-134.553-71.381-58.46433.219-85.144-78.542-98.051-49.363116.208-45.43620.958-42.432-23.345-41.297-21.967-37.68-33.135-33.101-33.813-23.99624.203-28.146-51.089-45.0757.26-46.638-50.56-39.535NANA
us-gaap:IncomeTaxExpenseBenefit ▅▆▇▇▇▂▆▆▇▄▅▆▆▆▇▅▅▅▇▇▃▁█▅▇▁▅▅▅▅-0.0030.1340.170.2150.169-0.1940.0720.0760.205-0.0250.0050.1240.0750.0990.1550.0570.0480.060.1890.158-0.113-0.3050.280.0280.205-0.2710.00.00.00.0
us-gaap:InterestExpense ▁▁▁▂▂▂▂▂▂▂▇▇██▅██▆██▇██████▇▇▇0.3550.5010.5380.580.6510.6330.6670.7020.7360.772.7342.7392.752.7691.8052.7692.7572.3752.752.762.4382.7772.7552.7582.7622.7582.9342.7232.7252.726
us-gaap:InterestIncomeExpenseNonoperatingNet ▃▃▃▅▄▇▇███▅▄▄▃▆▂▂▂▁▂▁▂▁▃▂▂-0.718-0.954-0.4660.889-0.0072.5322.3853.4913.3893.4071.0380.34-0.104-0.6981.845-1.663-1.726-1.73-2.533-1.894-2.309-1.361-2.642-1.3-2.055-1.915NANANANA
us-gaap:NetIncomeLoss ▁▃▃▆▂▃▂▃█▃▅▄▄▄▄▄▄▄▄▄▅▄▃▃▆▃▃▄▆▄-133.988-71.755-58.63433.004-85.313-78.348-98.123-49.439116.003-45.41120.953-42.556-23.42-41.396-22.122-37.737-33.183-33.161-34.002-24.15424.316-27.841-51.369-45.09857.055-46.367-50.56-39.53546.831-16.24
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁▃▃▆▂▃▂▃█▃▅▄▄▄-133.988-71.755-58.63433.004-85.313-78.348-98.123-49.439116.003-45.41120.953-42.556-23.421-41.396NANANANANANANANANANANANANANANANA
us-gaap:OperatingExpenses █▆▆▁▇▅▆▅▄▄▅▄▄▄▄▃▃▃▃▃▃▃▄▃▃▃▄▃▂▂158.199108.856122.99711.702128.025105.475108.4186.02878.74772.70688.13571.79967.19372.52466.3263.28960.40658.26263.19252.20462.76855.06772.88963.30861.23561.02164.07950.75740.78532.082
us-gaap:OperatingIncomeLoss ▁▃▃▆▂▂▂▃█▃▅▄▄▄▄▄▄▄▄▄▆▄▃▄▆▄▃▄▆▄-133.835-70.427-57.99832.33-85.137-81.074-100.436-52.854112.819-48.84319.92-42.772-23.241-40.599-23.812-36.017-31.409-31.371-31.28-22.10226.512-26.785-48.447-43.7759.315-44.723-47.974-37.09549.173-14.206
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax ▅▅▅▁▂▅▄▆▄▅▅▅▇▄▄▄▃▄▇▄▆▄▆▃▆█▆▇▅▅0.04-0.070.165-2.038-1.6150.281-0.4030.623-0.180.2910.2680.0720.958-0.527-0.195-0.578-0.994-0.2550.978-0.1840.38-0.6420.449-1.00.5081.7050.6991.1880.1850.01
us-gaap:OtherComprehensiveIncomeLossNetOfTax ▅▅▄▁▁▇▄▅▅▆▅▅▆▄▄▄▄▅▅▄▆▅▅▃▅█▅▆▅▄0.057-0.125-0.243-2.695-2.7441.93-0.5230.2380.4750.7330.2890.0411.011-0.577-0.186-0.222-0.366-0.060.373-0.3090.68-0.053-0.037-0.9910.1152.4110.0280.956-0.095-0.53
us-gaap:ProfitLoss ▁▃▃▆▂▃▂▃█▃▅▄▄▄▄▄-133.988-71.755-58.63433.004-85.313-78.348-98.123-49.439116.003-45.41120.953-42.556-23.421-41.396-33.894-24.459NANANANANANANANANANANANANANA
us-gaap:ResearchAndDevelopmentExpense █▅▅▃▄▃▃▃▃▃▄▃▃▃▃▃▃▃▃▂▃▂▃▃▃▃▃▂▂▁122.56774.67678.13258.47661.41454.90256.79849.96352.00850.49670.28456.44352.13856.97452.46850.33646.98146.73250.60740.55852.39243.6559.92452.07151.55550.53951.25840.61733.26925.65
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▂▂▃▂▂▂▁▂█▂▅▂▂▂▂▂▂▂▂▂▄▂▂▁▅▁▁▁▄▁24.36438.42964.99944.03242.88824.4017.97433.174191.56623.863108.05529.02743.95231.92530.73640.5530.26826.89135.52430.10289.2828.28224.44219.538120.5516.29816.10513.66289.95817.876
us-gaap:Revenues ▂▂▃▂▂▂▁▂█▂▅▂▂▂▂▂▂▂▂▂▄▂▂▁▅▁▁▁▄▁24.36438.42964.99944.03242.88824.4017.97433.174191.56623.863108.05529.02743.95231.92542.50827.27228.99726.89131.91230.10289.2828.28224.44219.538120.5516.29816.10513.66289.95817.876
us-gaap:SellingGeneralAndAdministrativeExpense ▆▆▇▁█▇▇▆▆▅▅▅▅▅32.55430.77942.249-48.98163.53549.60350.70735.82326.73922.2117.85115.35615.05515.55NANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:Assets ▆▆▇▆▆▇▇██▇▇▇▇▇██▃▁▁▂▂▁▂▂▃▁▂808.618787.301826.84812.015807.683824.377857.397893.964915.066812.397880.598855.641869.919867.611898.65894.892542.638441.756469.552486.213499.129442.535470.574499.247541.395435.54483.528NANANA
us-gaap:Liabilities █▅▅▄▅▄▃▂▂▃▄▄▄▄▃▃▂▂▂▂▂▂▂▂▂▁▁528.767397.028385.391341.084392.54346.748321.991280.246266.764303.903352.128365.059355.117348.822316.2304.123293.269290.784294.443288.597286.752266.312273.749262.692268.509231.653242.852NANANA
us-gaap:LiabilitiesAndStockholdersEquity ▆▆▇▆▆▇▇██▇▇▇▇▇██▃▁▁▂▂▁▂▂▃▁▂808.618787.301826.84812.015807.683824.377857.397893.964915.066812.397880.598855.641869.919867.611898.65894.892542.638441.756469.552486.213499.129442.535470.574499.247541.395435.54483.528NANANA
us-gaap:StockholdersEquity ▃▄▅▆▅▆▆██▆▆▆▆▆▇▇▂▁▁▂▂▁▂▂▃▂▂260.58371.002422.178451.66395.872458.358516.135594.447629.031489.223509.199471.311495.531499.518563.179571.498230.098131.701155.838178.345193.106156.952177.554217.284253.615184.616221.405NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:AssetsCurrent ▅▆▇▇▇▇▇██▆▇▇▇▇▇▇▃▂▂▂▂▁▁▂▂▁▁564.466621.694755.11737.484727.168736.405702.49786.48805.791579.0690.015678.783720.083717.163748.97741.456371.344256.581266.516253.462252.309184.001200.564232.573263.579155.4198.238NANANA
us-gaap:Cash ▅▄▃▃█▁▁▃▁▂▁▂▂▂▄▄█▃▃▃▃▃▃▃▄▄▆130.035100.73588.04680.551198.70849.41240.71590.7740.78372.27838.78371.59163.51669.559103.716104.875205.01886.67979.23992.6277.09496.19875.68595.488108.893119.114151.653NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▄▅█▆▅▂▂▂▁▁▁▇████▄▂▂▂▂▂▂▃▃▂▂▂▂▁353.361433.508678.393532.468429.269121.56126.266196.59274.58781.67389.258566.722643.803659.007673.658651.373290.277170.598173.782198.283190.411140.959153.324208.65236.536128.369165.455153.889182.66272.953
us-gaap:ShortTermInvestments ▃▂▁▃▄▆▆▆█▇▇▂153.851110.7248.144155.398256.317413.869407.491432.04586.174483.726532.14486.009NANA62.06NANANANANANANANANANANANANANANA
us-gaap:AccountsReceivableNetCurrent ▃▅▅▃▃▇▄▃▁▁█▃▄▁▁▁▁▁▂▁▂▁▂▁▂▁▂24.26640.54341.88326.25226.51958.5428.45519.2256.4536.02363.68423.18730.1899.9758.4528.6288.9337.24810.4487.69218.0885.93715.4057.37312.1836.96313.453NANANA
us-gaap:InventoryNet █▇▆▄▃▃▃▂▁24.5320.76416.5311.8038.5828.4086.8874.9081.981NA0.04.908NANANANANANANANANANANANANANANANANANA
us-gaap:InventoryFinishedGoods ██▅▂▁▂▁7.7997.7956.1135.0344.445.0014.298NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAssetsCurrent ▁▃▂█▂▂▂▄▅1.3092.5231.8076.0142.0522.2031.7173.6523.899NA2.224NANANANANANANANANANANANANANANANANANANA
us-gaap:PrepaidExpenseAndOtherAssetsCurrent ▁▂▁▁▁████▁▁▁▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁8.45816.15510.1611.5636.481134.028133.391133.715136.5967.5784.9292.86517.9973.424.82.8563.0135.9112.8893.9653.7054.6513.9883.6772.7315.7464.966NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:PropertyPlantAndEquipmentGross ▂▂▂▂▁▂▂▁▁▁█147.029144.567144.894143.804141.209143.283143.107142.31140.786139.005192.397NANANA189.117NANANA177.296NANANA176.747NANANA174.49NANANA
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment ██▇▇▆▆▆▆▅▅▁116.359113.634111.247107.651104.225103.225100.36499.10295.92193.17765.199NANANA59.641NANANA53.639NANANA47.727NANANA42.319NANANA
us-gaap:PropertyPlantAndEquipmentNet ▁▁▁▁▁▂▂▂▂▂██████▇▇▇▇███████30.6730.93333.64736.15336.98440.05842.74343.20844.86545.828127.198127.908128.829129.88129.476126.643122.591122.818123.657124.774126.264127.613129.02129.607130.451131.66132.171NANANA
us-gaap:LongTermInvestments ▇▆▁▁▁▁▄▂▂█▄▃105.75893.6790.2440.2470.2290.22361.11810.99910.915132.20355.8240.602NANA10.506NANANANANANANANANANANANANANANA
us-gaap:OperatingLeaseRightOfUseAsset █▁▁▁▁▁▁97.0915.0762.0431.2421.3771.6581.931NANANA0.0NANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAssetsNoncurrent ▄█▃▃▆▇█▆▄▃▃▂▄▄▄▃▃▂▂▁▁▁▁▁▁▁▁4.6179.1293.4334.0316.8628.6029.3727.0684.8144.1923.423.1675.2394.8814.5173.8093.2822.9852.1521.9931.7621.6582.0161.8391.8011.7081.596NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:AccountsPayableCurrent █▄▄▂▂▁▂▁▁▁▂▂▁▁▂▂▁▁▂▁▁▁▂▁▁▁▁48.98824.06124.7897.5535.0152.8656.0884.0554.063.7729.13910.1313.2223.5495.5096.4073.2612.956.2232.0393.4741.5436.5214.2343.9152.4334.551NANANA
us-gaap:AccruedLiabilitiesCurrent █▆▆▄▂▁▄▃▃▃▃▂▂▂▂▂▁▁▂▂▁▁▁▁▁▁▁147.801119.781119.52190.57250.46442.30983.81670.82566.54566.27866.12352.59849.49262.85963.78154.11748.53449.17950.91451.74847.94244.03847.93241.77446.2442.46648.985NANANA
us-gaap:ContractWithCustomerLiabilityCurrent ▆▃▂▂▃▃▁▁▁▃▄██25.23410.7256.5477.9129.8138.5310.490.2570.13612.10413.77137.69737.845NA16.67NANANANANANANANANANANANANANANA
us-gaap:LiabilitiesCurrent █▅▅▄▂▁▃▂▂▃▂▃▂▂▂▂▁▁▁▁▁▁▂▁▁▁▁232.764167.047163.187118.34877.57166.101102.74587.28682.81293.9289.033100.42690.55983.34277.25868.49859.77460.11365.12561.74466.44358.30367.18158.98863.50253.95762.754NANANA
us-gaap:OperatingLeaseLiabilityCurrent █▂▁▁▁▁▁10.7181.7241.1880.770.8010.90.983NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:OtherAccruedLiabilitiesCurrent ▃▇▆▇▅▃▂▃▄▃▃▇▆▅▄█▅▅▄▅▂▂▃▂▁▁▃5.0338.9268.0889.3367.7095.0654.5435.2236.0745.435.5379.6318.7557.5536.45810.337.4137.6435.886.9684.5624.1664.7624.1423.2433.4965.558NANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:OtherLiabilitiesNoncurrent ▃▃▃▃█▆▅▃▂▂▂▂▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁30.65938.33539.64237.639127.24289.12264.26636.04119.0589.9819.99310.2919.3188.5618.0476.696.2455.846.1914.7574.9915.2374.6070.7470.7020.6990.696NANANA
us-gaap:OperatingLeaseLiabilityNoncurrent █▁▁▁▁▁▁94.1963.3540.8530.4720.5720.6780.942NANANA0.0NANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo █▁▁▁13.4540.9090.8390.329NANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree █▁▁16.7980.7680.143NANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour █▁18.1930.766NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:StockholdersEquity ▃▄▅▆▅▆▆██▆▆▆▆▆▇▇▂▁▁▂▂▁▂▂▃▂▂260.58371.002422.178451.66395.872458.358516.135594.447629.031489.223509.199471.311495.531499.518563.179571.498230.098131.701155.838178.345193.106156.952177.554217.284253.615184.616221.405NANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▃▄▅▆▅▆▆██▆▆▆▆▆▇▇▂▁▁▂▂▁▂▂▃▂▂279.851390.273441.449470.931415.143477.629535.406613.718648.302508.494528.47490.582514.802518.789582.45590.769249.369150.972175.109197.616212.377176.223196.825236.555272.886203.887240.676NANANA
us-gaap:CommonStockValue ████▇▇▇▇▇▇▆▆▆▆▆▆▃▂▂▂▂▂▂▁▁▁▁0.9260.9210.9140.9090.9020.8890.8770.8720.8680.8610.8540.8480.8420.8340.8250.8180.710.6440.6370.6310.6270.6240.620.6120.6040.5930.59NANANA
us-gaap:AdditionalPaidInCapital █▇▇▆▅▄▄▃▃▂▁▁1443.9751420.4711399.7741370.3841344.9121319.3541300.7251280.3961265.7831242.461226.4531209.813NANA1160.094NANANANANANANA586.647574.979565.229553.411546.247NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ▁▂▃▃▃▄▄▅▅▄▅▅▅▅▆▆▆▆▇▇▇▇▇████-1179.754-1045.766-974.011-915.377-948.381-863.068-784.72-686.597-637.158-753.161-715.827-736.78-694.224-670.803-595.945-573.823-536.086-502.903-469.742-435.74-411.586-435.903-408.062-356.693-311.595-368.65-322.283NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▁▁▁▁▅█▆▆▆▅▄▃▃▂▄▅▅▅▅▅▅▅▅▅▆▆▃-4.567-4.624-4.499-4.256-1.5611.183-0.747-0.224-0.462-0.937-2.281-2.57-2.611-3.622-1.795-1.609-1.387-1.02-0.96-1.333-1.024-1.704-1.651-1.614-0.623-0.738-3.149NANANA
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue ▇▇█▆▆▆▆▄▆▅▃▄▃▁19.00119.38420.26917.89117.64416.91617.40214.79317.64216.4313.7114.32313.23110.878NANANANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▂▁▃▃█▁▁▂▂▄▂▃▂▂▃▂-26.543-44.984-7.228-1.349149.665-59.486-45.05-27.483-28.65222.48-17.4658.248-34.964-31.963-1.186-18.434NANANANANANANANANANANANANANA
us-gaap:NetCashProvidedByUsedInInvestingActivities ▆▄█▇█▇▆█▆▆▁▅▆▆▆▆-57.533-196.719143.76898.855153.85556.009-25.033152.76818.77-26.487-462.856-89.20514.63915.29919.9979.541NANANANANANANANANANANANANANA
us-gaap:NetCashProvidedByUsedInFinancingActivities ▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁█2.381-2.085.6594.2254.649-1.19-0.284-3.2362.754-3.5342.8183.925.0922.0453.413370.025NANANANANANANANANANANANANANA
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect ▄▃▆▆█▅▄▆▅▅▁▄▅▅▅█-80.147-244.885145.925103.199307.709-4.706-70.326122.005-7.086-7.585-477.464-77.081-15.204-14.65122.285361.096NANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:IncreaseDecreaseInAccountsPayable ▃▃█▄▃▂▃▃▃▁▂▅▃▂▂▄▃▂▄▂▃▁▃▃▃▂▃▃▃▃-0.344-0.66916.2912.52.163-3.2232.033-0.0050.288-5.367-0.9926.909-0.327-1.96-0.8983.1460.311-3.2734.184-1.4351.931-4.9782.2870.3191.482-2.1181.6561.6390.1090.081
us-gaap:IncreaseDecreaseInAccountsReceivable ▄▅▆▅▃▇▆▆▅▁█▅▇▅▅▅▅▅▅▄▆▄▆▅▅▅▅▅▅▅-16.532-1.33614.493-0.617-31.98830.0859.2312.7720.43-57.66140.497-7.00220.2141.523-0.176-0.3051.685-3.22.756-10.39612.151-9.4688.032-4.815.22-6.49-7.9715.259-4.9793.65
us-gaap:IncreaseDecreaseInInventories ▇█▇▆▂▃▄▆▄▁▁▁3.5734.2883.9693.190.4951.5211.9792.9271.9810.00.00.0NANANANANANANANANANANANANANANANANANA
us-gaap:NetCashProvidedByUsedInOperatingActivities ▂▁▃▃█▁▁▂▂▄▂▃▂▂▃▂-26.543-44.984-7.228-1.349149.665-59.486-45.05-27.483-28.65222.48-17.4658.248-34.964-31.963-1.186-18.434NANANANANANANANANANANANANANA
us-gaap:NetIncomeLoss ▁▃▃▆▂▃▂▃█▃▅▄▄▄▄▄▄▄▄▄▅▄▃▃▆▃▃▄▆▄-133.988-71.755-58.63433.004-85.313-78.348-98.123-49.439116.003-45.41120.953-42.556-23.42-41.396-22.122-37.737-33.183-33.161-34.002-24.15424.316-27.841-51.369-45.09857.055-46.367-50.56-39.53546.831-16.24
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁▃▃▆▂▃▂▃█▃▅▄▄▄-133.988-71.755-58.63433.004-85.313-78.348-98.123-49.439116.003-45.41120.953-42.556-23.421-41.396NANANANANANANANANANANANANANANANA
us-gaap:ProfitLoss ▁▃▃▆▂▃▂▃█▃▅▄▄▄▄▄-133.988-71.755-58.63433.004-85.313-78.348-98.123-49.439116.003-45.41120.953-42.556-23.421-41.396-33.894-24.459NANANANANANANANANANANANANANA
us-gaap:ShareBasedCompensation ███▇▇▇▇▆▇▇▆▆▅▅▄▄▄▄▄▄▄▃▃▃▃▃▄▄▁▁19.00119.38420.26917.89117.64416.91617.40214.79317.64216.4313.7114.32313.23110.8789.9319.6289.5718.4097.8768.5128.4047.347.4496.8446.9426.4468.9648.2690.670.795
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities ▆▄█▇█▇▆█▆▆▁▅▆▆▆▆-57.533-196.719143.76898.855153.85556.009-25.033152.76818.77-26.487-462.856-89.20514.63915.29919.9979.541NANANANANANANANANANANANANANA
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▄▂▆▂▂▂▄▅▄▂▇▃▅▅██▃▂▁▁▁▃▁▂▂▂▆▄▄▆1.6970.5182.390.4190.7260.4591.7451.8111.7230.4833.1681.1471.8681.8373.5083.380.9760.6360.1460.0870.1210.8980.3090.6790.5410.4482.5761.591.6212.331
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities ▁▁▁▁▁▁▁▁▁▁▁▁▁▁▁█2.381-2.085.6594.2254.649-1.19-0.284-3.2362.754-3.5342.8183.925.0922.0453.413370.025NANANANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value926000.0921000.0914000.0909000.0902000.0889000.0877000.0872000.0868000.0861000.0854000.0848000.0842000.0834000.0825000.0818000.0710000.0644000.0637000.0631000.0627000.0624000.0620000.0612000.0604000.0593000.0590000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1

Common Stock Shares Issued

us-gaap:CommonStockSharesIssued

us-gaap:CommonStockSharesIssued


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value929291909088878786868584848382817064636362626161605959
Percentage of CommonStockSharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Common Stock Shares Outstanding

us-gaap:CommonStockSharesOutstanding

us-gaap:CommonStockSharesOutstanding


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value929291909088878786868584848382817064636362626161605959
Percentage of CommonStockSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding


Weighted
Period End2020-09-302020-06-302019-09-302019-06-302018-09-302018-06-302017-06-302016-06-302015-06-302014-06-30
Value93898791848369696837
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic


Weighted
Period End2020-09-302020-06-302019-09-302019-06-302018-09-302018-06-302017-06-302016-06-302015-06-302014-06-30
Value90898786848369625913
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Share Outstanding Basic And Diluted

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted


Weighted
Period End2021-06-302021-03-312020-06-302020-03-312019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-03-312015-09-302015-03-312014-09-302014-03-31
Value9291898885848382756964626260591313
Percentage of WeightedAverageNumberOfShareOutstandingBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount


Antidilutive
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302016-06-302015-09-302015-06-302015-03-312014-09-302014-06-302014-03-31
Value117.84.29.28.79.24.49.59.38.86.6153.816481846
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareBasic


Earnings
Period End2020-09-302020-06-302019-09-302019-06-302018-09-302018-06-302017-06-302016-06-302015-06-302014-06-30
Value0.36-0.95-0.571.34-0.5-0.28-0.480.390.951.36
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareDiluted


Earnings
Period End2020-09-302020-06-302019-09-302019-06-302018-09-302018-06-302017-06-302016-06-302015-06-302014-06-30
Value0.35-0.95-0.571.26-0.5-0.28-0.480.350.830.58
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic And Diluted

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:EarningsPerShareBasicAndDiluted


Earnings
Period End2021-06-302021-03-312020-06-302020-03-312019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312015-12-312015-09-302015-03-312014-12-312014-09-302014-03-31
Value-1.45-0.78-0.95-0.89-0.530.25-0.5-0.28-0.5-0.24-0.5-0.46-0.52-0.54-0.38-0.45-0.85-0.74-0.78-2.5-2.93-1.23
Percentage of EarningsPerShareBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Allocated Share Based Compensation Expense

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AllocatedShareBasedCompensationExpense


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value19192017171617141716131413109.9319.6289.5718.4097.8768.5128.4047.347.4496.8446.9426.4468.9648.2690.670.795
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax78.050.40.040.641.169.30.044.69.268.90.049.330.134.10.023.731.631.30.028.39.426.00.035.05.839.60.060.50.74.4

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation

us-gaap:ResearchAndDevelopmentExpense


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value1012131110101010109.5787.7628.4657.8946.375.7475.5385.6214.9014.4415.0745.0594.4964.2264.1054.4344.2225.1184.8920.4080.475
Percentage of AllocatedShareBasedCompensationExpense56.263.067.062.861.162.962.168.959.258.356.659.159.758.657.957.558.758.356.459.660.261.356.760.063.965.557.159.260.959.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax43.831.80.025.525.143.60.030.75.540.10.029.218.020.00.013.718.618.20.016.95.715.90.021.03.725.90.035.80.52.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ResearchAndDevelopmentExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:SellingGeneralAndAdministrativeExpenses


Allocated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value8.327.1636.6936.6556.8646.2796.6014.6087.1926.8525.9485.8585.3374.508
Percentage of AllocatedShareBasedCompensationExpense43.837.033.037.238.937.137.931.140.841.743.440.940.341.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax34.118.60.015.116.025.70.013.93.828.70.020.212.114.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:SellingGeneralAndAdministrativeExpenses0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-133.931-71.88-58.87730-88.057-76.418-98.646-49.201116-44.67821-42.515-22.409-41.973-22.308-37.959-33.549-33.221-33.629-24.46324-27.894-51.406-46.08957-43.956-50.532-38.57946-16.77
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.7-187.00.068.8-205.3-313.20.0-148.360.8-187.20.0-146.5-51.0-131.50.0-93.6-110.8-123.50.0-81.328.0-98.60.0-235.947.4-269.70.0-282.452.0-93.8

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
Value-134.553-71.381-58.46433-85.144-78.542-98.051-49.363116-45.43620-42.432-23.345-41.297-21.967-37.68-33.135-33.101-33.813-23.99624-28.146-51.089-45.0757-46.638-50.56-39.535
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-552.3-185.70.075.4-198.5-321.90.0-148.860.7-190.40.0-146.2-53.1-129.40.0-92.9-109.5-123.10.0-79.727.1-99.50.0-230.747.5-286.20.0-289.4

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxExpenseBenefit


Income
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-3000.0134000.0170000.0215000.0169000.0-194000.072000.076000.0205000.0-25000.05000.0124000.075000.099000.0155000.057000.048000.060000.0189000.0158000.0-113000.0-305000.0280000.028000.0205000.0-271000.00000
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.00.30.00.50.4-0.80.00.20.1-0.10.00.40.20.30.00.10.20.20.00.5-0.1-1.10.00.10.2-1.70.00.00.00.0

Interest Expense

us-gaap:InterestExpense

us-gaap:InterestExpense


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value0.3550.5010.5380.580.6510.6330.6670.7020.7360.772.7342.7392.752.7691.8052.7692.7572.3752.752.762.4382.7772.7552.7582.7622.7582.9342.7232.7252.726
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.51.30.01.31.52.60.02.10.43.20.09.46.38.70.06.89.18.80.09.22.79.80.014.12.316.90.019.93.015.2

Interest Income Expense Nonoperating Net

us-gaap:InterestIncomeExpenseNonoperatingNet

us-gaap:InterestIncomeExpenseNonoperatingNet


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-0.718-0.954-0.4660.889-0.0072.5322.3853.4913.3893.4071.0380.34-0.104-0.6981.845-1.663-1.726-1.73-2.533-1.894-2.309-1.361-2.642-1.3-2.055-1.915
Percentage of InterestIncomeExpenseNonoperatingNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.9-2.50.02.0-0.010.40.010.51.814.30.01.2-0.2-2.20.0-4.1-5.7-6.40.0-6.3-2.6-4.80.0-6.7-1.7-11.7

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-133.988-71.755-58.63433-85.313-78.348-98.123-49.439116-45.41120-42.556-23.42-41.396-22.122-37.737-33.183-33.161-34.002-24.15424-27.841-51.369-45.09857-46.367-50.56-39.53546-16.24
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.9-186.70.075.0-198.9-321.10.0-149.060.6-190.30.0-146.6-53.3-129.70.0-93.1-109.6-123.30.0-80.227.2-98.40.0-230.847.3-284.50.0-289.452.1-90.8

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-133.988-71.755-58.63433-85.313-78.348-98.123-49.439116-45.41120-42.556-23.421-41.396
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.9-186.70.075.0-198.9-321.10.0-149.060.6-190.30.0-146.6-53.3-129.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Expenses

us-gaap:OperatingExpenses

us-gaap:OperatingExpenses


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value158108122111281051088678728871677266636058635262557263616164504032
Percentage of OperatingExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax649.3283.30.026.6298.5432.30.0259.341.1304.70.0247.4152.9227.20.0156.1199.6216.70.0173.470.3194.70.0324.050.8374.40.0371.545.3179.5

Operating Income Loss

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-133.835-70.427-57.99832-85.137-81.074-100.436-52.854112-48.84319-42.772-23.241-40.599-23.812-36.017-31.409-31.371-31.28-22.10226-26.785-48.447-43.7759-44.723-47.974-37.09549-14.206
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.3-183.30.073.4-198.5-332.30.0-159.358.9-204.70.0-147.4-52.9-127.20.0-88.8-103.8-116.70.0-73.429.7-94.70.0-224.049.2-274.40.0-271.554.7-79.5

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value40000.0-70000.0165000.0-2038000.0-1615000.0281000.0-403000.0623000.0-180000.0291000.0268000.072000.0958000.0-527000.0-195000.0-578000.0-994000.0-255000.0978000.0-184000.0380000.0-642000.0449000.0-1000000.0508000.01705000.0699000.01188000.0185000.010000.0
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.2-0.20.0-4.6-3.81.20.01.9-0.11.20.00.22.2-1.70.0-1.4-3.3-0.90.0-0.60.4-2.30.0-5.10.410.50.08.70.20.1

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value40000.0-70000.0165000.0-2038000.0-1615000.0281000.0-403000.0623000.0-180000.0291000.0268000.072000.0958000.0-527000.0
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.2-0.20.0-4.6-3.81.20.01.9-0.11.20.00.22.2-1.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Other Comprehensive Income Loss Net Of Tax

us-gaap:OtherComprehensiveIncomeLossNetOfTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value57000.0-125000.0-243000.0-2695000.0-2744000.01930000.0-523000.0238000.0475000.0733000.0289000.041000.01011000.0-577000.0-186000.0-222000.0-366000.0-60000.0373000.0-309000.0680000.0-53000.0-37000.0-991000.0115000.02411000.028000.0956000.0-95000.0-530000.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.2-0.30.0-6.1-6.47.90.00.70.23.10.00.12.3-1.80.0-0.5-1.2-0.20.0-1.00.8-0.20.0-5.10.114.80.07.0-0.1-3.0

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-133.988-71.755-58.63433-85.313-78.348-98.123-49.439116-45.41120-42.556-23.421-41.396-33.894-24.459
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.9-186.70.075.0-198.9-321.10.0-149.060.6-190.30.0-146.6-53.3-129.70.0-60.3

Research And Development Expense

us-gaap:ResearchAndDevelopmentExpense

us-gaap:ResearchAndDevelopmentExpense


Research
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value1227478586154564952507056525652504646504052435952515051403325
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax503.1194.30.0132.8143.2225.00.0150.627.1211.60.0194.4118.6178.50.0124.1155.2173.80.0134.758.7154.30.0266.542.8310.10.0297.337.0143.5

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value2438644442247.9743319123108294331304030263530892824191201616138917
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:BalanceSheetLocation, us-gaap:ValuationAllowancesAndReservesType

fgen:ContractLiabilities, fgen:RebatesAndDiscounts


Revenue
Period End2021-06-302021-03-312020-12-312020-09-30
Value-2.216131.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.041.620.82.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.041.620.82.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:ContractLiabilities fgen:RebatesAndDiscounts100.0100.0100.0100.0

fgen:GrossAccountsReceivable, fgen:RebatesAndDiscounts


Revenue
Period End2020-12-312020-09-30
Value-9.34.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-14.39.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-14.39.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:GrossAccountsReceivable fgen:RebatesAndDiscounts100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

fgen:DevelopmentAndOtherRevenue


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value1914212018192820402335292931303030
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax80.638.033.146.944.279.7358.862.321.4100.032.7100.067.4100.0100.075.5100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax80.638.033.146.944.279.7358.862.321.4100.032.7100.067.4100.0100.075.5100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DevelopmentAndOtherRevenue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:DrugProductRevenue


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value-8.6488.48-0.0180.6868.2380.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-35.522.1-0.01.619.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-35.522.1-0.01.619.20.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DrugProductRevenue100.0100.0100.0100.0100.00.0

us-gaap:Product


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value13152922154.955-35.2030.5790.00.0640.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax54.940.044.951.536.620.3-441.51.70.00.059.90.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax54.940.044.951.536.620.3-441.51.70.00.059.90.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:DevelopmentAndOtherRevenue, country:JP, fgen:AstellasCollaborationAgreement


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value0.0990.080.8070.0860.1640.1630.0710.5370.3690.2460.3350.4741.1420.4490.4580.5170.317
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.21.20.20.40.70.91.60.21.00.31.62.61.41.51.31.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.21.20.20.40.70.91.60.21.00.31.62.61.41.51.31.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DevelopmentAndOtherRevenue country:JP fgen:AstellasCollaborationAgreement100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:DevelopmentAndOtherRevenue, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1610171513142417231930232326
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax69.728.627.734.632.159.7310.551.612.479.628.682.353.483.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax69.728.627.734.632.159.7310.551.612.479.628.682.353.483.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DevelopmentAndOtherRevenue fgen:UnitedStatesRestOfWorldAndChina fgen:AstraZenecaAgreements100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:DevelopmentAndOtherRevenue, srt:Europe, fgen:AstellasCollaborationAgreement


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value2.5463.5314.1274.6514.6024.5743.7092.996164.6134.1194.6585.0034.7234.5474.805
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.49.26.310.610.718.746.59.08.819.33.816.011.414.814.811.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.49.26.310.610.718.746.59.08.819.33.816.011.414.814.811.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DevelopmentAndOtherRevenue srt:Europe fgen:AstellasCollaborationAgreement100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Product, country:CN, fgen:AstraZenecaAgreements


Revenue
Period End2021-06-302021-03-31
Value1110
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax48.427.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax48.427.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product country:CN fgen:AstraZenecaAgreements100.0100.0

us-gaap:Product, country:CN, fgen:DirectSales


Revenue
Period End2021-06-302021-03-31
Value1.65.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.613.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.613.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product country:CN fgen:DirectSales100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:TypeOfArrangement

us-gaap:Product, fgen:DirectSales


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value1.6114.956154.955
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.612.936.620.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.612.936.620.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:DirectSales100.0100.0100.0100.0

us-gaap:Product, fgen:SalesToFalikang


Revenue
Period End2021-06-302021-03-31
Value1110
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax48.327.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax48.327.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:SalesToFalikang100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

us-gaap:Product, fgen:DirectSales, fgen:DiscountsAndRebates


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value-0.618-0.562-4.095-0.417
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.5-1.5-9.5-1.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.5-1.5-9.5-1.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:DirectSales fgen:DiscountsAndRebates100.0100.0100.0100.0

us-gaap:Product, fgen:DirectSales, us-gaap:SalesReturnsAndAllowances


Revenue
Period End2021-06-302021-03-312020-06-30
Value-0.0010.089-0.045
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.00.2-0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.00.2-0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:DirectSales us-gaap:SalesReturnsAndAllowances100.0100.0100.0

us-gaap:Product, fgen:SalesToFalikang, fgen:ConstrainedForFutureRecognition


Revenue
Period End2021-03-31
Value-3.931
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-10.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-10.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:SalesToFalikang fgen:ConstrainedForFutureRecognition100.0

us-gaap:Product, fgen:SalesToFalikang, fgen:IncreaseInDeferredRevenue


Revenue
Period End2021-06-30
Value-5.381
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-22.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-22.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:SalesToFalikang fgen:IncreaseInDeferredRevenue100.0

us-gaap:Product, fgen:SalesToFalikang, fgen:NetTransferPrice


Revenue
Period End2021-06-302021-03-31
Value1714
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax70.437.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax70.437.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:SalesToFalikang fgen:NetTransferPrice100.0100.0

us-gaap:Product, fgen:SalesToFalikang, fgen:ProfitShare


Revenue
Period End2021-06-302021-03-31
Value-9.573-10.064
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-39.3-26.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-39.3-26.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:SalesToFalikang fgen:ProfitShare100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:ValuationAllowancesAndReservesType

us-gaap:Product, fgen:ContractualSalesRebate


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
Value-2.475-1.966-1.372-0.376-0.106-0.043
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-3.8-4.5-3.2-1.5-1.3-0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-3.8-4.5-3.2-1.5-1.3-0.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:ContractualSalesRebate100.0100.0100.0100.0100.0100.0

us-gaap:Product, fgen:NonKeyAccountHospitalListingAward


Revenue
Period End2020-12-312020-09-302020-06-30
Value-3.83-2.93-2.566
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.9-6.7-6.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.9-6.7-6.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:NonKeyAccountHospitalListingAward100.0100.0100.0

us-gaap:Product, fgen:OtherDiscountsAndRebates


Revenue
Period End2020-12-312020-09-302020-06-30
Value-0.411-0.313-0.202
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.6-0.7-0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.6-0.7-0.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product fgen:OtherDiscountsAndRebates100.0100.0100.0

us-gaap:Product, us-gaap:SalesReturnsAndAllowances


Revenue
Period End2020-12-312020-09-30
Value-0.039-0.008
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Product us-gaap:SalesReturnsAndAllowances100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

country:CN, fgen:AstraZenecaAgreements


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
Value-1.390.7060.4410.1530.0710.0190.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.11.61.00.60.90.10.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-2.11.61.00.60.90.10.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:CN fgen:AstraZenecaAgreements100.0100.0100.0100.0100.0100.00.00.00.00.00.00.00.00.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

country:JP, fgen:AstellasCollaborationAgreement, fgen:DrugProductRevenue


Revenue
Period End2021-06-302021-03-312020-06-30
Value-2.04.08.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-8.210.419.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-8.210.419.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:JP fgen:AstellasCollaborationAgreement fgen:DrugProductRevenue100.0100.0100.0

fgen:UnitedStatesAndRestOfWorld, fgen:AstraZenecaAgreements, fgen:DrugProductRevenue


Revenue
Period End2020-09-30
Value4.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:UnitedStatesAndRestOfWorld fgen:AstraZenecaAgreements fgen:DrugProductRevenue100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:TransactionType, us-gaap:ValuationAllowancesAndReservesType

fgen:APIShipment, fgen:DrugProductRevenue


Revenue
Period End2021-06-302021-03-31
Value2.04.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.210.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.210.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:APIShipment fgen:DrugProductRevenue100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

fgen:AstellasAgreement, fgen:DrugProductRevenue


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value-1.9744.030.0-3.9578.238
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-8.110.50.0-9.019.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-8.110.50.0-9.019.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:AstellasAgreement fgen:DrugProductRevenue100.0100.00.0100.0100.0

fgen:AstraZenecaAgreements, fgen:DrugProductRevenue


Revenue
Period End2021-06-302021-03-312020-12-312020-09-30
Value-6.6744.5-0.0434.643
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-27.411.7-0.110.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-27.411.7-0.110.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:AstraZenecaAgreements fgen:DrugProductRevenue100.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ValuationAllowancesAndReservesType

fgen:ConstrainedForFutureRecognition


Revenue
Period End2021-03-31
Value3.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:ConstrainedForFutureRecognition100.0

fgen:ContractualSalesRebate


Revenue
Period End2020-12-312020-09-302020-06-302020-03-31
Value2.52.01.40.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.84.53.31.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.84.53.31.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:ContractualSalesRebate100.0100.0100.0100.0

fgen:DeferredForFutureRecognition


Revenue
Period End2021-06-30
Value5.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax22.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax22.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DeferredForFutureRecognition100.0

fgen:DiscountsAndRebates


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value0.60.64.10.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.51.69.61.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.51.69.61.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DiscountsAndRebates100.0100.0100.0100.0

fgen:DrugProductRevenue


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-30
Value-8.6488.48-0.0180.6868.238
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-35.522.1-0.01.619.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-35.522.1-0.01.619.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:DrugProductRevenue100.0100.0100.0100.0100.0

fgen:NonKeyAccountHospitalListingAward


Revenue
Period End2020-12-312020-09-302020-06-30
Value3.82.92.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.86.66.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.86.66.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax fgen:NonKeyAccountHospitalListingAward100.0100.0100.0

Revenues

us-gaap:Revenues

us-gaap:Revenues


Revenues
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value2438644442247.9743319123108294331422728263130892824191201616138917
Percentage of Revenues100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0138.367.395.8100.089.8100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:SellingGeneralAndAdministrativeExpense


Selling
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value323042-48.98163495035262217151515
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax133.680.165.0-111.2148.1203.3635.9108.014.093.116.552.934.348.7

Assets

us-gaap:Assets

us-gaap:Assets


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value808787826812807824857893915812880855869867898894542441469486499442470499541435483
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities

us-gaap:Liabilities

us-gaap:Liabilities


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value528397385341392346321280266303352365355348316304293290294288286266273262268231242
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets65.450.446.642.048.642.137.631.329.237.440.042.740.840.235.234.054.065.862.759.457.560.258.252.649.653.250.2

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value808787826812807824857893915812880855869867898894542441469486499442470499541435483
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value260371422451395458516594629489509471495499563571230131155178193156177217253184221
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets32.247.151.155.649.055.660.266.568.760.257.855.157.057.662.763.942.429.833.236.738.735.537.743.546.842.445.8

Assets Current

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value564621755737727736702786805579690678720717748741371256266253252184200232263155198
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets69.879.091.390.890.089.381.988.088.171.378.479.382.882.783.382.968.458.156.852.150.541.642.646.648.735.741.0

Cash

us-gaap:Cash

us-gaap:Cash


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value130100888019849409040723871636910310420586799277967595108119151
Percentage of Cash100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets16.112.810.69.924.66.04.710.24.58.94.48.47.38.011.511.737.819.616.919.015.421.716.119.120.127.331.4

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-31
Value353433678532429121126196748189566643659673651290170173198190140153208236128165153182727638
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets43.755.182.065.653.114.714.722.08.210.110.166.274.076.075.072.853.538.637.040.838.131.932.641.843.729.534.20.00.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:GeographicDistribution

us-gaap:GeographicDistributionForeign


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value85766651322911182631212524273219222424252526
Percentage of CashAndCashEquivalentsAtCarryingValue24.117.69.79.67.624.59.49.234.938.624.54.53.84.24.82.97.814.314.012.613.418.4
Percentage of Assets10.59.78.06.34.13.61.42.02.83.92.53.02.83.23.62.14.25.55.25.15.15.9
Percentage of Assets us-gaap:GeographicDistributionForeign0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Short Term Investments

us-gaap:ShortTermInvestments

us-gaap:ShortTermInvestments


Short
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value1531108.1441552564134074325864835328662
Percentage of ShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets19.014.11.019.131.750.247.548.364.159.560.410.16.9

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent

us-gaap:AccountsReceivableNetCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value24404126265828196.4536.0236323309.9758.4528.6288.9337.248107.692185.937157.373126.96313
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.05.15.13.23.37.13.32.20.70.77.22.73.51.10.91.01.61.62.21.63.61.33.31.52.31.62.8

Inventory Net

us-gaap:InventoryNet

us-gaap:InventoryNet


Inventory
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-09-30
Value242016118.5828.4086.8874.9081.9810.04.908
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0
Percentage of Assets3.02.62.01.51.11.00.80.50.20.00.6

us-gaap:InventoryNet us-gaap:StatementGeographical

country:CN


Inventory
Period End2020-12-312019-12-31
Value116.887
Percentage of InventoryNet71.5100.0
Percentage of Assets1.40.8
Percentage of Assets country:CN0.00.0

country:US


Inventory
Period End2020-12-31
Value4.715
Percentage of InventoryNet28.5
Percentage of Assets0.6
Percentage of Assets country:US0.0

Inventory Finished Goods

us-gaap:InventoryFinishedGoods

us-gaap:InventoryFinishedGoods


Inventory
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value7799000.07795000.06113000.05034000.04440000.05001000.04298000.0
Percentage of InventoryFinishedGoods100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.01.00.70.60.50.60.5

Other Assets Current

us-gaap:OtherAssetsCurrent

us-gaap:OtherAssetsCurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Value1309000.02523000.01807000.06014000.02052000.02203000.01717000.03652000.03899000.02224000.0
Percentage of OtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.30.20.70.30.30.20.40.40.3

Prepaid Expense And Other Assets Current

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent


Prepaid
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value8.4581610116.4811341331331367.5784.9292.865173.424.82.8563.0135.9112.8893.9653.7054.6513.9883.6772.7315.7464.966
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.02.11.21.40.816.315.615.014.90.90.60.32.10.40.50.30.61.30.60.80.71.10.80.70.51.31.0

Property Plant And Equipment Gross

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:PropertyPlantAndEquipmentGross


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value147144144143141143143142140139192189177176174
Percentage of PropertyPlantAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets18.218.417.517.717.517.416.715.915.417.121.821.037.837.636.1

us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType

fgen:LaboratoryEquipment


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value191818171717171616161619181817
Percentage of PropertyPlantAndEquipmentGross13.112.812.512.412.312.112.111.911.911.98.510.310.510.39.8
Percentage of Assets2.42.42.22.22.12.12.01.91.82.01.92.23.93.93.5
Percentage of Assets fgen:LaboratoryEquipment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ComputerEquipment


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value9.2059.1079.5459.1248.938.8798.3997.2276.6556.656.4736.0065.6785.7015.106
Percentage of PropertyPlantAndEquipmentGross6.36.36.66.36.36.25.95.14.74.83.43.23.23.22.9
Percentage of Assets1.11.21.21.11.11.11.00.80.70.80.70.71.21.21.1
Percentage of Assets us-gaap:ComputerEquipment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ConstructionInProgress


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value1.4070.2280.761.5061.2251.2121.7922.3321.8880.6070.367100.1090.1930.519
Percentage of PropertyPlantAndEquipmentGross1.00.20.51.00.90.81.31.61.30.40.25.50.10.10.3
Percentage of Assets0.20.00.10.20.20.10.20.30.20.10.01.20.00.00.1
Percentage of Assets us-gaap:ConstructionInProgress0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:FurnitureAndFixtures


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value6.1266.1956.1286.115.8735.8835.8225.7895.7785.6435.695.5755.5335.3615.082
Percentage of PropertyPlantAndEquipmentGross4.24.34.24.24.24.14.14.14.14.13.02.93.13.02.9
Percentage of Assets0.80.80.70.80.70.70.70.60.60.70.60.61.21.11.1
Percentage of Assets us-gaap:FurnitureAndFixtures0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:LeaseholdImprovements


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value10210210210110010110110110110110193939392
Percentage of PropertyPlantAndEquipmentGross69.870.770.470.370.971.071.071.271.972.852.649.652.852.853.2
Percentage of Assets12.713.012.312.512.412.311.811.311.112.511.510.419.919.819.2
Percentage of Assets us-gaap:LeaseholdImprovements0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MachineryAndEquipment


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value8.3878.2318.3128.0127.668.2298.2178.6918.4618.3968.3820.0
Percentage of PropertyPlantAndEquipmentGross5.75.75.75.65.45.75.76.16.06.04.40.0
Percentage of Assets1.01.01.01.00.91.01.01.00.91.01.00.0
Percentage of Assets us-gaap:MachineryAndEquipment0.00.00.00.00.00.00.00.00.00.00.00.0

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment


Accumulated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value1161131111071041031009995936559534742
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets14.414.413.513.312.912.511.711.110.511.57.46.611.410.18.8

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value30303336364042434445127127128129129126122122123124126127129129130131132
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.83.94.14.54.64.95.04.84.95.614.414.914.815.014.414.222.627.826.325.725.328.827.426.024.130.227.3

us-gaap:PropertyPlantAndEquipmentNet us-gaap:StatementGeographical

country:CN


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value12152322131516
Percentage of PropertyPlantAndEquipmentNet38.636.118.617.211.111.912.2
Percentage of Assets1.61.82.72.52.93.33.3
Percentage of Assets country:CN0.00.00.00.00.00.00.0

country:US


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value2027103107109113116
Percentage of PropertyPlantAndEquipmentNet61.463.981.482.888.988.187.8
Percentage of Assets2.53.211.811.923.424.124.0
Percentage of Assets country:US0.00.00.00.00.00.00.0

Long Term Investments

us-gaap:LongTermInvestments

us-gaap:LongTermInvestments


Long
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value105930.2440.2470.2290.223611010132554010
Percentage of LongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets13.111.90.00.00.00.07.11.21.216.36.34.71.2

Operating Lease Right Of Use Asset

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OperatingLeaseRightOfUseAsset


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-31
Value975.0762.0431.2421.3771.6581.9310.0
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets12.00.60.20.20.20.20.20.0

us-gaap:OperatingLeaseRightOfUseAsset us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AccountingStandardsUpdate201901


Operating
Period End2021-06-30
Value93
Percentage of OperatingLeaseRightOfUseAsset96.0
Percentage of Assets11.5
Percentage of Assets us-gaap:AccountingStandardsUpdate2019010.0

us-gaap:OperatingLeaseRightOfUseAsset us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:AccountingStandardsUpdate201901, fgen:LeaseAmendment, fgen:ShorensteinPropertiesLLC


Operating
Period End2021-06-01
Value93
Percentage of OperatingLeaseRightOfUseAsset0.0
Percentage of Assets0.0
Percentage of Assets us-gaap:AccountingStandardsUpdate201901 fgen:LeaseAmendment fgen:ShorensteinPropertiesLLC0.0

us-gaap:OperatingLeaseRightOfUseAsset us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:BeijingEconomicTechnologicalDevelopmentArea


Operating
Period End2021-03-31
Value3.4
Percentage of OperatingLeaseRightOfUseAsset67.0
Percentage of Assets0.4
Percentage of Assets fgen:BeijingEconomicTechnologicalDevelopmentArea0.0

us-gaap:OperatingLeaseRightOfUseAsset us-gaap:StatementGeographical

country:CN


Operating
Period End2020-12-312019-12-312018-12-31
Value1.9961.8560.0
Percentage of OperatingLeaseRightOfUseAsset97.796.10.0
Percentage of Assets0.20.20.0
Percentage of Assets country:CN0.00.00.0

country:US


Operating
Period End2020-12-312019-12-312018-12-31
Value0.0470.0750.0
Percentage of OperatingLeaseRightOfUseAsset2.33.90.0
Percentage of Assets0.00.00.0
Percentage of Assets country:US0.00.00.0

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent

us-gaap:OtherAssetsNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value4617000.09129000.03433000.04031000.06862000.08602000.09372000.07068000.04814000.04192000.03420000.03167000.05239000.04881000.04517000.03809000.03282000.02985000.02152000.01993000.01762000.01658000.02016000.01839000.01801000.01708000.01596000.0
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.61.20.40.50.81.01.10.80.50.50.40.40.60.60.50.40.60.70.50.40.40.40.40.40.30.40.3

Accounts Payable Current

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value4824247.5535.0152.8656.0884.0554.063.7729.139103.2223.5495.5096.4073.2612.956.2232.0393.4741.5436.5214.2343.9152.4334.551
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.13.13.00.90.60.30.70.50.40.51.01.20.40.40.60.70.60.71.30.40.70.31.40.80.70.60.9

Accrued Liabilities Current

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value147119119905042837066666652496263544849505147444741464248
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets18.315.214.511.26.25.19.87.97.38.27.56.15.77.27.16.08.911.110.810.69.610.010.28.48.59.810.1

Contract With Customer Liability Current

us-gaap:ContractWithCustomerLiabilityCurrent

us-gaap:ContractWithCustomerLiabilityCurrent


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value25106.5477.9129.8138.5310.490.2570.1361213373716
Percentage of ContractWithCustomerLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.11.40.81.01.21.00.10.00.01.51.64.44.41.9

us-gaap:ContractWithCustomerLiabilityCurrent us-gaap:StatementGeographical, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

country:CN, fgen:AccruedAndOtherCurrentLiabilities, fgen:AstraZenecaAgreements


Contract
Period End2020-12-31
Value7.0
Percentage of ContractWithCustomerLiabilityCurrent106.9
Percentage of Assets0.8
Percentage of Assets country:CN fgen:AccruedAndOtherCurrentLiabilities fgen:AstraZenecaAgreements0.0

us-gaap:ContractWithCustomerLiabilityCurrent us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

srt:Europe, fgen:AstellasAgreement, fgen:DrugProductRevenue


Contract
Period End2021-06-30
Value11
Percentage of ContractWithCustomerLiabilityCurrent46.8
Percentage of Assets1.5
Percentage of Assets srt:Europe fgen:AstellasAgreement fgen:DrugProductRevenue0.0

srt:Europe, fgen:AstellasCollaborationAgreement, fgen:DrugProductRevenue


Contract
Period End2021-06-302020-12-31
Value111.4
Percentage of ContractWithCustomerLiabilityCurrent46.821.4
Percentage of Assets1.50.2
Percentage of Assets srt:Europe fgen:AstellasCollaborationAgreement fgen:DrugProductRevenue0.00.0

us-gaap:ContractWithCustomerLiabilityCurrent us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

fgen:AstraZenecaAgreements, fgen:DrugProductRevenue


Contract
Period End2021-06-30
Value11
Percentage of ContractWithCustomerLiabilityCurrent44.4
Percentage of Assets1.4
Percentage of Assets fgen:AstraZenecaAgreements fgen:DrugProductRevenue0.0

us-gaap:ContractWithCustomerLiabilityCurrent us-gaap:ValuationAllowancesAndReservesType

fgen:DrugProductRevenue


Contract
Period End2021-06-30
Value11
Percentage of ContractWithCustomerLiabilityCurrent44.4
Percentage of Assets1.4
Percentage of Assets fgen:DrugProductRevenue0.0

Liabilities Current

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value232167163118776610287829389100908377685960656166586758635362
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets28.821.219.714.69.68.012.09.89.011.610.111.710.49.68.67.711.013.613.912.713.313.214.311.811.712.413.0

Operating Lease Liability Current

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityCurrent


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value101.7241.1880.770.8010.90.983
Percentage of OperatingLeaseLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.30.20.10.10.10.10.1

us-gaap:OperatingLeaseLiabilityCurrent us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AccountingStandardsUpdate201901


Operating
Period End2021-06-30
Value9.221
Percentage of OperatingLeaseLiabilityCurrent86.0
Percentage of Assets1.1
Percentage of Assets us-gaap:AccountingStandardsUpdate2019010.0

Other Accrued Liabilities Current

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:OtherAccruedLiabilitiesCurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value5.0338.9268.0889.3367.7095.0654.5435.2236.0745.435.5379.6318.7557.5536.458107.4137.6435.886.9684.5624.1664.7624.1423.2433.4965.558
Percentage of OtherAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.61.11.01.11.00.60.50.60.70.70.61.11.00.90.71.21.41.71.31.40.90.91.00.80.60.81.1

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OtherLiabilitiesNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value30383937127896436199.9819.993109.3188.5618.0476.696.2455.846.1914.7574.9915.2374.6070.7470.7020.6990.696
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.84.94.84.615.810.87.54.02.11.21.11.21.11.00.90.71.21.31.31.01.01.21.00.10.10.20.1

Operating Lease Liability Noncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-31
Value943.3540.8530.4720.5720.6780.9420.0
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets11.60.40.10.10.10.10.10.0

us-gaap:OperatingLeaseLiabilityNoncurrent us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AccountingStandardsUpdate201901


Operating
Period End2021-06-30
Value91
Percentage of OperatingLeaseLiabilityNoncurrent97.6
Percentage of Assets11.4
Percentage of Assets us-gaap:AccountingStandardsUpdate2019010.0

Lessee Operating Lease Liability Payments Due Year Two

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value130.9090.8390.329
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearTwo100.0100.0100.0100.0
Percentage of Assets1.70.10.10.0

Lessee Operating Lease Liability Payments Due Year Three

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree


Lessee
Period End2021-06-302021-03-312020-12-31
Value160.7680.143
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearThree100.0100.0100.0
Percentage of Assets2.10.10.0

Lessee Operating Lease Liability Payments Due Year Four

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour


Lessee
Period End2021-06-302021-03-31
Value180.766
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFour100.0100.0
Percentage of Assets2.20.1

Operating Lease Liability

us-gaap:OperatingLeaseLiability

us-gaap:OperatingLeaseLiability


Operating
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value1045.0782.0411.2421.925
Percentage of OperatingLeaseLiability100.0100.0100.0100.0100.0
Percentage of Assets13.00.60.20.20.2

us-gaap:OperatingLeaseLiability us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:AccountingStandardsUpdate201901, fgen:LeaseAmendment, fgen:ShorensteinPropertiesLLC


Operating
Period End2021-06-01
Value101
Percentage of OperatingLeaseLiability0.0
Percentage of Assets0.0
Percentage of Assets us-gaap:AccountingStandardsUpdate201901 fgen:LeaseAmendment fgen:ShorensteinPropertiesLLC0.0

us-gaap:OperatingLeaseLiability us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:BeijingEconomicTechnologicalDevelopmentArea


Operating
Period End2021-03-31
Value3.4
Percentage of OperatingLeaseLiability67.0
Percentage of Assets0.4
Percentage of Assets fgen:BeijingEconomicTechnologicalDevelopmentArea0.0

Lessee Operating Lease Liability Payments Due

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value1255.5352.1241.288
Percentage of LesseeOperatingLeaseLiabilityPaymentsDue100.0100.0100.0100.0
Percentage of Assets15.50.70.30.2

Lessee Operating Lease Liability Undiscounted Excess Amount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value200.4570.0830.046
Percentage of LesseeOperatingLeaseLiabilityUndiscountedExcessAmount100.0100.0100.0100.0
Percentage of Assets2.50.10.00.0

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value260371422451395458516594629489509471495499563571230131155178193156177217253184221
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets32.247.151.155.649.055.660.266.568.760.257.855.157.057.662.763.942.429.833.236.738.735.537.743.546.842.445.8

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-31
Value279390441470415477535613648508528490514518582590249150175197212176196236272203240-60.833-46.252
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets34.649.653.458.051.457.962.468.770.862.660.057.359.259.864.866.046.034.237.340.642.539.841.847.450.446.849.80.00.0

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value-4.567-4.624-4.499-4.256-1.5611.183-0.747-0.224-0.462-0.937-2.281-2.57-2.611-3.622-1.795-0.96-1.651-3.149-3.508-0.167
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-1.6-1.2-1.0-0.9-0.40.2-0.1-0.0-0.1-0.2-0.4-0.5-0.5-0.7-0.3-0.5-0.8-1.35.80.4
Percentage of Assets-0.6-0.6-0.5-0.5-0.20.1-0.1-0.0-0.1-0.1-0.3-0.3-0.3-0.4-0.2-0.2-0.4-0.70.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value1443142013991370134413191300128012651242122612091191117311606255865464137
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest516.0364.0317.1291.0324.0276.2242.9208.6195.2244.3232.1246.6231.5226.1199.2357.4298.1227.0-67.6-81.3
Percentage of Assets178.6180.4169.3168.8166.5160.0151.7143.2138.3152.9139.3141.4137.0135.2129.1133.3124.7113.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value0.9260.9210.9140.9090.9020.8890.8770.8720.8680.8610.8540.8480.8420.8340.8250.6370.620.590.1320.132
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.30.20.20.20.20.20.20.10.10.20.20.20.20.20.10.40.30.2-0.2-0.3
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value1919191919191919191919191919191919192727
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest6.94.94.44.14.64.03.63.13.03.83.63.93.73.73.311.09.88.0-45.8-59.9
Percentage of Assets2.42.42.32.42.42.32.22.22.12.42.22.32.22.22.14.14.14.00.00.0
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value-1179.754-1045.766-974.011-915.377-948.381-863.068-784.72-686.597-637.158-753.161-715.827-736.78-694.224-670.803-595.945-469.742-408.062-322.283-262.779-247.836
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-421.6-268.0-220.6-194.4-228.4-180.7-146.6-111.9-98.3-148.1-135.5-150.2-134.9-129.3-102.3-268.3-207.3-133.9432.0535.8
Percentage of Assets-145.9-132.8-117.8-112.7-117.4-104.7-91.5-76.8-69.6-92.7-81.3-86.1-79.8-77.3-66.3-100.0-86.7-66.70.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value926000.0921000.0914000.0909000.0902000.0889000.0877000.0872000.0868000.0861000.0854000.0848000.0842000.0834000.0825000.0818000.0710000.0644000.0637000.0631000.0627000.0624000.0620000.0612000.0604000.0593000.0590000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1

Additional Paid In Capital

us-gaap:AdditionalPaidInCapital

us-gaap:AdditionalPaidInCapital


Additional
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value1443142013991370134413191300128012651242122612091160586574565553546
Percentage of AdditionalPaidInCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets178.6180.4169.3168.8166.5160.0151.7143.2138.3152.9139.3141.4129.1124.7115.2104.4127.1113.0

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


Retained
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value-1179800000.0-1045800000.0-974010000.0-915380000.0-948380000.0-863070000.0-784720000.0-686600000.0-637160000.0-753160000.0-715830000.0-736780000.0-694220000.0-670800000.0-595940000.0-573820000.0-536090000.0-502900000.0-469740000.0-435740000.0-411590000.0-435900000.0-408060000.0-356690000.0-311600000.0-368650000.0-322280000.0
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-145.9-132.8-117.8-112.7-117.4-104.7-91.5-76.8-69.6-92.7-81.3-86.1-79.8-77.3-66.3-64.1-98.8-113.8-100.0-89.6-82.5-98.5-86.7-71.4-57.6-84.6-66.7

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax


Accumulated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value-4567000.0-4624000.0-4499000.0-4256000.0-1561000.01183000.0-747000.0-224000.0-462000.0-937000.0-2281000.0-2570000.0-2611000.0-3622000.0-1795000.0-1609000.0-1387000.0-1020000.0-960000.0-1333000.0-1024000.0-1704000.0-1651000.0-1614000.0-623000.0-738000.0-3149000.0
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-0.6-0.6-0.5-0.5-0.20.1-0.1-0.0-0.1-0.1-0.3-0.3-0.3-0.4-0.2-0.2-0.3-0.2-0.2-0.3-0.2-0.4-0.4-0.3-0.1-0.2-0.7

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1919201717161714171613141310
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1919201717161714171613141310
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-26.543-44.984-7.228-1.349149-59.486-45.05-27.483-28.65222-17.4658.248-34.964-31.963-1.186-18.434
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-108.9-117.1-11.1-3.1349.0-243.8-565.0-82.8-15.094.2-16.228.4-79.6-100.1-3.9-45.5

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-57.533-196.7191439815356-25.03315218-26.487-462.856-89.2051415199.541
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-236.1-511.9221.2224.5358.7229.5-313.9460.59.8-111.0-428.4-307.333.347.965.123.5

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value2.381-2.085.6594.2254.649-1.19-0.284-3.2362.754-3.5342.8183.925.0922.0453.413370
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.8-5.48.79.610.8-4.9-3.6-9.81.4-14.82.613.511.66.411.1912.5

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-80.147-244.885145103307-4.706-70.326122-7.086-7.585-477.464-77.081-15.204-14.65122361
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-329.0-637.2224.5234.4717.5-19.3-881.9367.8-3.7-31.8-441.9-265.5-34.6-45.972.5890.5

Increase Decrease In Accounts Payable

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsPayable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-0.344-0.669162.52.163-3.2232.033-0.0050.288-5.367-0.9926.909-0.327-1.96-0.8983.1460.311-3.2734.184-1.4351.931-4.9782.2870.3191.482-2.1181.6561.6390.1090.081
Percentage of IncreaseDecreaseInAccountsPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Accounts Receivable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInAccountsReceivable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-16.532-1.33614-0.617-31.988309.23120.43-57.66140-7.002201.523-0.176-0.3051.685-3.22.756-10.39612-9.4688.032-4.815.22-6.49-7.9715.259-4.9793.65
Percentage of IncreaseDecreaseInAccountsReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Inventories

us-gaap:IncreaseDecreaseInInventories

us-gaap:IncreaseDecreaseInInventories


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value3573000.04288000.03969000.03190000.0495000.01521000.01979000.02927000.01981000.0000
Percentage of IncreaseDecreaseInInventories100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-26.543-44.984-7.228-1.349149-59.486-45.05-27.483-28.65222-17.4658.248-34.964-31.963-1.186-18.434
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-108.9-117.1-11.1-3.1349.0-243.8-565.0-82.8-15.094.2-16.228.4-79.6-100.1-3.9-45.5

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-133.988-71.755-58.63433-85.313-78.348-98.123-49.439116-45.41120-42.556-23.42-41.396-22.122-37.737-33.183-33.161-34.002-24.15424-27.841-51.369-45.09857-46.367-50.56-39.53546-16.24
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.9-186.7-90.275.0-198.9-321.1-1230.5-149.060.6-190.319.4-146.6-53.3-129.7-72.0-93.1-109.6-123.3-95.7-80.227.2-98.4-210.2-230.847.3-284.5-313.9-289.452.1-90.8

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-133.988-71.755-58.63433-85.313-78.348-98.123-49.439116-45.41120-42.556-23.421-41.396
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.9-186.7-90.275.0-198.9-321.1-1230.5-149.060.6-190.319.4-146.6-53.3-129.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-133.988-71.755-58.63433-85.313-78.348-98.123-49.439116-45.41120-42.556-23.421-41.396-33.894-24.459
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-549.9-186.7-90.275.0-198.9-321.1-1230.5-149.060.6-190.319.4-146.6-53.3-129.7-110.3-60.3

Share Based Compensation

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value19192017171617141716131413109.9319.6289.5718.4097.8768.5128.4047.347.4496.8446.9426.4468.9648.2690.670.795
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-57.533-196.7191439815356-25.03315218-26.487-462.856-89.2051415199.541
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-236.1-511.9221.2224.5358.7229.5-313.9460.59.8-111.0-428.4-307.333.347.965.123.5

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value1697000.0518000.02390000.0419000.0726000.0459000.01745000.01811000.01723000.0483000.03168000.01147000.01868000.01837000.03508000.03380000.0976000.0636000.0146000.087000.0121000.0898000.0309000.0679000.0541000.0448000.02576000.01590000.01621000.02331000.0
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value2.381-2.085.6594.2254.649-1.19-0.284-3.2362.754-3.5342.8183.925.0922.0453.413370
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.8-5.48.79.610.8-4.9-3.6-9.81.4-14.82.613.511.66.411.1912.5

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value9.29101011131314
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value32.9426.6320.2514.8211.3510.127.1
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Liabilities

us-gaap:DeferredTaxLiabilities

us-gaap:DeferredTaxLiabilities


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value5073000.08266000.00202000.0215000.0853000.01266000.0
Percentage of DeferredTaxLiabilities100.0100.00.0100.0100.0100.0100.0

Deferred Tax Assets Net

us-gaap:DeferredTaxAssetsNet

us-gaap:DeferredTaxAssetsNet


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value5073000.08266000.00202000.0215000.0853000.01266000.0
Percentage of DeferredTaxAssetsNet100.0100.00.0100.0100.0100.0100.0

Unrecognized Tax Benefits

us-gaap:UnrecognizedTaxBenefits

us-gaap:UnrecognizedTaxBenefits


Unrecognized
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value483228231924
Percentage of UnrecognizedTaxBenefits100.0100.0100.0100.0100.0100.0

us-gaap:UnrecognizedTaxBenefits us-gaap:IncomeTaxAuthority

fgen:FederalAndState


Unrecognized
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value483227231924191312
Percentage of UnrecognizedTaxBenefits99.999.999.8100.399.8100.10.00.00.0

Deferred Tax Assets Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance

us-gaap:DeferredTaxAssetsValuationAllowance


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value33721319315912811694
Percentage of DeferredTaxAssetsValuationAllowance100.0100.0100.0100.0100.0100.0100.0

fgen:AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid

fgen:AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4.5081.329.1267.5887.9271.7252.866-0.1765.688-0.4162.9253.9725.1922.146
Percentage of AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value4.5031.3139.1217.5817.9141.7132.861-0.185.681-0.4232.9193.9665.1842.137
Percentage of AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid99.999.599.999.999.899.399.8102.399.9101.799.899.899.899.6

us-gaap:CommonStock


Adjustments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value0.0050.0070.0050.0070.0130.0120.0050.0040.0070.0070.0060.0060.0080.009
Percentage of AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid0.10.50.10.10.20.70.2-2.30.1-1.70.20.20.20.4

fgen:CoPromotionExpenses us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement

fgen:CoPromotionExpenses

us-gaap:SellingGeneralAndAdministrativeExpenses, fgen:AstraZenecaAgreements


Co
Period End2020-12-312020-09-30
Value128.8
Percentage of CoPromotionExpenses100.0100.0

fgen:CollaborationServicesAndOtherRevenue us-gaap:TypeOfArrangement

fgen:CollaborationServicesAndOtherRevenue

fgen:AstellasCollaborationAgreement


Collaboration
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value2.6453.6114.9354.7364.7664.7373.7783.533174.8594.4555.1316.1455.1720.3480.4450.4450.340.2430.4360.3260.3520.6740.8680.7190.6341.0280.890.8660.75
Percentage of CollaborationServicesAndOtherRevenue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:CommercialMilestone us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:SubsequentEventType

fgen:CommercialMilestone

fgen:LicenseAgreementWithEluminex, us-gaap:SubsequentEvent


Commercial
Period End2021-07-19
Value36
Percentage of CommercialMilestone100.0

fgen:ContractWithCustomerLiabilityAdditions us-gaap:ProductOrService

fgen:ContractWithCustomerLiabilityAdditions

us-gaap:Product


Contract
Period End2020-12-31
Value5.874
Percentage of ContractWithCustomerLiabilityAdditions100.0

fgen:ContractWithCustomerLiabilityAdditions us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

us-gaap:Product, fgen:ContractLiabilities, fgen:DirectSales


Contract
Period End2021-06-302021-03-31
Value-0.5391.422
Percentage of ContractWithCustomerLiabilityAdditions0.00.0

fgen:ContractWithCustomerLiabilityAdditions us-gaap:ProductOrService, us-gaap:TypeOfArrangement

fgen:DrugProductRevenue, fgen:AstellasCollaborationAgreement


Contract
Period End2021-03-31
Value11
Percentage of ContractWithCustomerLiabilityAdditions0.0

fgen:ContractWithCustomerLiabilityAdditions us-gaap:TypeOfArrangement

fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-31
Value1815
Percentage of ContractWithCustomerLiabilityAdditions0.00.0

fgen:ContractWithCustomerLiabilityDeduction us-gaap:ProductOrService

fgen:ContractWithCustomerLiabilityDeduction

us-gaap:Product


Contract
Period End2020-12-31
Value1734000.0
Percentage of ContractWithCustomerLiabilityDeduction100.0

fgen:ContractWithCustomerLiabilityDeduction us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

us-gaap:Product, fgen:ContractLiabilities, fgen:DirectSales


Contract
Period End2021-06-302021-03-31
Value1877000.0533000.0
Percentage of ContractWithCustomerLiabilityDeduction0.00.0

fgen:ContractWithCustomerLiabilityIncreaseDecreaseFromCurrentTranslationAndOther us-gaap:ProductOrService

fgen:ContractWithCustomerLiabilityIncreaseDecreaseFromCurrentTranslationAndOther

us-gaap:Product


Contract
Period End2020-12-31
Value-153000.0
Percentage of ContractWithCustomerLiabilityIncreaseDecreaseFromCurrentTranslationAndOther100.0

fgen:ContractWithCustomerLiabilityIncreaseDecreaseFromCurrentTranslationAndOther us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

us-gaap:Product, fgen:ContractLiabilities, fgen:DirectSales


Contract
Period End2021-06-302021-03-31
Value-230000.047000.0
Percentage of ContractWithCustomerLiabilityIncreaseDecreaseFromCurrentTranslationAndOther0.00.0

fgen:CostOfGoodsAndServicesSoldOperatingExpense

fgen:CostOfGoodsAndServicesSoldOperatingExpense


Cost
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value3078000.03401000.02616000.02207000.03076000.0970000.0905000.0242000.00000
Percentage of CostOfGoodsAndServicesSoldOperatingExpense100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

fgen:DrugProductRevenueFromRelatedParty us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:DrugProductRevenueFromRelatedParty

fgen:Astellas


Drug
Period End2021-06-302020-06-30
Value-2.08.2
Percentage of DrugProductRevenueFromRelatedParty100.0100.0

fgen:DrugProductRevenueFromRelatedParty us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TransactionType

fgen:Astellas, fgen:APIShipment


Drug
Period End2021-03-31
Value4.0
Percentage of DrugProductRevenueFromRelatedParty0.0

fgen:DrugProductRevenueFromRelatedParty us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

fgen:Astellas, us-gaap:CollaborativeArrangement


Drug
Period End2020-09-302020-06-30
Value-3.98.2
Percentage of DrugProductRevenueFromRelatedParty0.0100.0

fgen:DrugProductRevenueFromRelatedParty us-gaap:TypeOfArrangement

fgen:AstellasCollaborationAgreement


Drug
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-30
Value-1.9744.03-3.9578.2380.00.00.0
Percentage of DrugProductRevenueFromRelatedParty98.70.00.0100.50.00.00.0

fgen:EquityMethodInvestmentIncreaseDecreaseFromCurrencyTranslation us-gaap:EquityMethodInvestmentNonconsolidatedInvestee

fgen:EquityMethodInvestmentIncreaseDecreaseFromCurrencyTranslation

fgen:BeijingFalikangPharmaceuticalCoLtd


Equity
Period End2021-06-302021-03-31
Value37000.0-5000.0
Percentage of EquityMethodInvestmentIncreaseDecreaseFromCurrencyTranslation100.0100.0

fgen:FutureManufacturingClinicalRegulatoryAndCommercialMilestonePayments us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:SubsequentEventType

fgen:FutureManufacturingClinicalRegulatoryAndCommercialMilestonePayments

fgen:LicenseAgreementWithEluminex, us-gaap:SubsequentEvent


Future
Period End2021-07-19
Value64
Percentage of FutureManufacturingClinicalRegulatoryAndCommercialMilestonePayments100.0

fgen:IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities

fgen:IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-44000.0-29000.019000.0-81000.0101000.0-216000.090000.0-137000.022000.0219000.00000
Percentage of IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

fgen:IncreaseDecreaseInRevenueDueToOutOfPeriodAdjustments

fgen:IncreaseDecreaseInRevenueDueToOutOfPeriodAdjustments


Increase
Period End2020-09-30
Value-2100000.0
Percentage of IncreaseDecreaseInRevenueDueToOutOfPeriodAdjustments100.0

fgen:InitialUpfrontPayment us-gaap:TypeOfArrangement

fgen:InitialUpfrontPayment

fgen:HiFiBiOAgreement


Initial
Period End2021-06-16
Value25
Percentage of InitialUpfrontPayment100.0

fgen:InterestAndOtherIncomeFromRelatedParty us-gaap:TypeOfArrangement

fgen:InterestAndOtherIncomeFromRelatedParty

fgen:AstellasCollaborationAgreement


Interest
Period End2020-09-302019-09-30
Value-13000.00
Percentage of InterestAndOtherIncomeFromRelatedParty100.00.0

fgen:InterestIncomeAndOtherIncomeExpensesNet

fgen:InterestIncomeAndOtherIncomeExpensesNet


Interest
Period End2021-06-302021-03-312020-06-302020-03-31
Value-363000.0-453000.0644000.03165000.0
Percentage of InterestIncomeAndOtherIncomeExpensesNet100.0100.0100.0100.0

fgen:InvestmentLossInUnconsolidatedVariableInterestEntity

fgen:InvestmentLossInUnconsolidatedVariableInterestEntity


Investment
Period End2021-06-302021-03-312020-12-31
Value563000.0-240000.0-189000.0
Percentage of InvestmentLossInUnconsolidatedVariableInterestEntity100.0100.0100.0

fgen:LicenseFeesAndMilestonesRevenue us-gaap:TypeOfArrangement

fgen:LicenseFeesAndMilestonesRevenue

fgen:AstellasCollaborationAgreement


License
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value140.00.00.0111170.00.0140.03.6554.1254.2783.2493.6944.37133.3134.0295.124.864.6924.4873.5063.7182.742
Percentage of LicenseFeesAndMilestonesRevenue100.00.00.00.0100.0100.00.00.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:MaximumFutureMilestonePayments us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

fgen:MaximumFutureMilestonePayments

fgen:ResearchAndPreClinicalStageDevelopmentPrograms


Maximum
Period End2021-06-302021-03-31
Value34810
Percentage of MaximumFutureMilestonePayments100.0100.0

fgen:PaymentsToAcquireAvailableForSaleSecuritiesAndTermDeposit

fgen:PaymentsToAcquireAvailableForSaleSecuritiesAndTermDeposit


Payments
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value8.1540.00.00.0382555029764661100.0540.044
Percentage of PaymentsToAcquireAvailableForSaleSecuritiesAndTermDeposit100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:PercentageOfOutstandingSharesOfAcquireeSoldByAcquirer us-gaap:BusinessAcquisition, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:PercentageOfOutstandingSharesOfAcquireeSoldByAcquirer

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:AstraZenecaAB, fgen:FibroGenBeijing


Percentage
Period End2020-09-15
Value48.9
Percentage of PercentageOfOutstandingSharesOfAcquireeSoldByAcquirer100.0

fgen:PercentageOfOutstandingSharesOfAcquireeSoldByAcquirer us-gaap:BusinessAcquisition, us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:AstraZenecaAB, fgen:FibroGenBeijing


Percentage
Period End2020-09-15
Value48.9
Percentage of PercentageOfOutstandingSharesOfAcquireeSoldByAcquirer100.0

fgen:PotentialMilestones us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:PotentialMilestones

country:JP, fgen:AstellasCollaborationAgreement


Potential
Period End2020-12-312019-09-302005-06-30
Value1512132
Percentage of PotentialMilestones100.0100.0100.0

fgen:ProductRevenue us-gaap:TypeOfArrangement

fgen:ProductRevenue

fgen:AstellasCollaborationAgreement


Product
Period End2021-06-302021-03-312020-06-302020-03-31
Value11100.00.0
Percentage of ProductRevenue100.0100.00.00.0

fgen:RepaymentsOfFinanceLeaseLiabilities

fgen:RepaymentsOfFinanceLeaseLiabilities


Repayments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value2.0273.2993.3663.2623.1782.8143.1152.962.8333.0170.0
Percentage of RepaymentsOfFinanceLeaseLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

fgen:RevenueGrossFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

fgen:RevenueGrossFromContractWithCustomerExcludingAssessedTax

us-gaap:Product


Revenue
Period End2020-12-312020-09-302020-06-302019-12-312019-09-30
Value3527192.1810.622
Percentage of RevenueGrossFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0

fgen:RevenueGrossFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:TypeOfArrangement

us-gaap:Product, fgen:DirectSales


Revenue
Period End2021-06-302021-03-312020-06-302020-03-31
Value2.235.429195.372
Percentage of RevenueGrossFromContractWithCustomerExcludingAssessedTax0.00.0100.00.0

fgen:RevenueGrossTransferPriceFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService, us-gaap:TypeOfArrangement

fgen:RevenueGrossTransferPriceFromContractWithCustomerExcludingAssessedTax

us-gaap:Product, fgen:SalesToFalikang


Revenue
Period End2021-06-302021-03-31
Value2624
Percentage of RevenueGrossTransferPriceFromContractWithCustomerExcludingAssessedTax100.0100.0

fgen:ReversalOfPreviouslyAccruedLongTermCoPromotionExpenses us-gaap:TypeOfArrangement

fgen:ReversalOfPreviouslyAccruedLongTermCoPromotionExpenses

fgen:AstraZenecaAgreements


Reversal
Period End2020-09-30
Value84
Percentage of ReversalOfPreviouslyAccruedLongTermCoPromotionExpenses100.0

fgen:UnconsolidatedVariableInterestEntityInvestmentIncome

fgen:UnconsolidatedVariableInterestEntityInvestmentIncome


Unconsolidated
Period End2021-06-30
Value562000.0
Percentage of UnconsolidatedVariableInterestEntityInvestmentIncome100.0

fgen:UnconsolidatedVariableInterestEntityInvestmentLoss

fgen:UnconsolidatedVariableInterestEntityInvestmentLoss


Unconsolidated
Period End2021-03-31
Value240000.0
Percentage of UnconsolidatedVariableInterestEntityInvestmentLoss100.0

fgen:UnrealizedLossGainOnEquityInvestments

fgen:UnrealizedLossGainOnEquityInvestments


Unrealized
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value18000.06000.0-21000.010000.019000.08000.051000.0
Percentage of UnrealizedLossGainOnEquityInvestments100.0100.0100.0100.0100.0100.0100.0

fgen:VariableConsiderationPaymentReceivedFromEstimatedFutureCoDevelopmentBilling us-gaap:StatementGeographical

fgen:VariableConsiderationPaymentReceivedFromEstimatedFutureCoDevelopmentBilling

fgen:UnitedStatesRestOfWorldAndChina


Variable
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value34495290115186149172-26.3-27.6-32.8284
Percentage of VariableConsiderationPaymentReceivedFromEstimatedFutureCoDevelopmentBilling100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

srt:Europe


Variable
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-31
Value1024313138429.412-5.1
Percentage of VariableConsiderationPaymentReceivedFromEstimatedFutureCoDevelopmentBilling31.449.560.235.233.122.76.37.419.4

us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments

us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments


Accretion
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value-636000.0-131000.00-125000.0-121000.0143000.0313000.0897000.01107000.01350000.0626000.0-121000.0-186000.0-277000.0
Percentage of AccretionAmortizationOfDiscountsAndPremiumsInvestments100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments

us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments


Availableforsale
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value000-258000.000000087000.00048000.065000.030000.0037000.000114000.00
Percentage of AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments0.00.00.0100.00.00.00.00.00.00.0100.00.00.0100.0100.0100.00.0100.00.00.0100.00.0

us-gaap:BusinessCombinationAcquisitionRelatedCosts us-gaap:BusinessAcquisition, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:BusinessCombinationAcquisitionRelatedCosts

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:FibroGenBeijing


Business
Period End2020-07-31
Value2500000.0
Percentage of BusinessCombinationAcquisitionRelatedCosts100.0

us-gaap:BusinessCombinationConsiderationTransferred1 us-gaap:BusinessAcquisition, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:BusinessCombinationConsiderationTransferred1

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:AcquiredLicense, fgen:FibroGenBeijing


Business
Period End2020-07-31
Value2500000.0
Percentage of BusinessCombinationConsiderationTransferred1100.0

us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice

fgen:AstellasCollaborationAgreement


Contract
Period End2021-03-31
Value4000000.0
Percentage of ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice100.0

us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized

country:CN, fgen:AstraZenecaAgreements


Contract
Period End2020-09-30
Value-2.0
Percentage of ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized100.0

country:JP, fgen:AstellasCollaborationAgreement


Contract
Period End2020-09-302020-06-302020-03-312019-09-302018-06-30
Value0.10.10.11214
Percentage of ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized-5.00.00.00.00.0

fgen:UnitedStatesRestOfWorldAndChina, fgen:AstellasCollaborationAgreement


Contract
Period End2020-09-302020-06-30
Value-0.6-0.2
Percentage of ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized30.00.0

fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value0.24.23.5410.9200.2
Percentage of ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized0.00.00.00.00.00.00.0

srt:Europe, fgen:AstellasCollaborationAgreement


Contract
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-31
Value0.40.41.31.60.92.91290.10.7
Percentage of ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized0.00.0-65.00.00.00.00.00.00.0

us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

country:JP, fgen:AstellasCollaborationAgreement, fgen:DrugProductRevenue


Contract
Period End2020-09-30
Value4.0
Percentage of ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized-200.0

us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice

srt:Europe, fgen:AstellasAgreement, fgen:DrugProductRevenue


Contract
Period End2021-03-31
Value11
Percentage of ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice100.0

srt:Europe, fgen:AstellasCollaborationAgreement, fgen:DrugProductRevenue


Contract
Period End2021-03-31
Value11
Percentage of ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice100.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerLiabilityRevenueRecognized

fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-31
Value1110
Percentage of ContractWithCustomerLiabilityRevenueRecognized100.0100.0

us-gaap:Depreciation

us-gaap:Depreciation


Depreciation
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value2.5192.7233.0072.9342.8692.8682.4323.1922.7792.7441.8691.611.5641.5191.5171.511.5471.5251.521.5131.5051.5021.4611.4221.4081.3881.141.4870.9310.912
Percentage of Depreciation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations


Effect
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value1548000.0-1102000.03726000.01468000.0-460000.0-39000.041000.0-44000.042000.0-44000.039000.0-44000.029000.0-32000.061000.0-36000.0
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EquityMethodInvestmentSoldCarryingAmount us-gaap:BusinessAcquisition, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:EquityMethodInvestmentSoldCarryingAmount

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:AstraZenecaAB, fgen:FibroGenBeijing


Equity
Period End2020-09-15
Value7300000.0
Percentage of EquityMethodInvestmentSoldCarryingAmount100.0

us-gaap:EquityMethodInvestmentSoldCarryingAmount us-gaap:BusinessAcquisition, us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:AstraZenecaAB, fgen:FibroGenBeijing


Equity
Period End2020-09-15
Value7300000.0
Percentage of EquityMethodInvestmentSoldCarryingAmount100.0

us-gaap:FinanceLeaseInterestExpense

us-gaap:FinanceLeaseInterestExpense


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value242000.0385000.0421000.0462000.0534000.0515000.0547000.0578000.0609000.0640000.0
Percentage of FinanceLeaseInterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseInterestPaymentOnLiability

us-gaap:FinanceLeaseInterestPaymentOnLiability


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value243000.0385000.0428000.0458000.0493000.0517000.0556000.0587000.0618000.0435000.0
Percentage of FinanceLeaseInterestPaymentOnLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseRightOfUseAssetAmortization

us-gaap:FinanceLeaseRightOfUseAssetAmortization


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1.7772.6162.4832.6392.6532.5942.5872.582.5712.5690.00.00.00.0
Percentage of FinanceLeaseRightOfUseAssetAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:GainLossOnDispositionOfAssets

us-gaap:GainLossOnDispositionOfAssets


Gain
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-312014-09-30
Value-936000.03000.00032000.00010000.000-53000.000-7000.004000.000002000.0010000.00
Percentage of GainLossOnDispositionOfAssets100.0100.00.00.0100.00.00.0100.00.00.0100.00.00.0100.00.0100.00.00.00.00.0100.00.0100.00.0

us-gaap:IncomeLossFromEquityMethodInvestments us-gaap:EquityMethodInvestmentNonconsolidatedInvestee

us-gaap:IncomeLossFromEquityMethodInvestments

fgen:BeijingFalikangPharmaceuticalCoLtd


Income
Period End2021-06-302021-03-31
Value83000.0240000.0
Percentage of IncomeLossFromEquityMethodInvestments100.0100.0

us-gaap:IncomeLossFromEquityMethodInvestments us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:Falikang


Income
Period End2021-06-302021-03-31
Value-600000.0-200000.0
Percentage of IncomeLossFromEquityMethodInvestments-722.9-83.3

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value270.25227367.723-41.224124.5670.1810.736153.486-12.305-1.066
Percentage of IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInContractWithCustomerLiability


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value1517-0.848-2.1920.121470.974-4.097-44.238-2.58-24.691-0.7120-0.005-1.847
Percentage of IncreaseDecreaseInContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities

us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-7.022-1.043-1.106-91.086392428158.675-0.156-0.3720.8730.6870.4481.2820.4020.348-0.4131.509-0.154-0.1660.7083.9360.1260.0830.08-0.5170.445-0.2790.101
Percentage of IncreaseDecreaseInOtherNoncurrentLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInOtherOperatingAssets

us-gaap:IncreaseDecreaseInOtherOperatingAssets


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-2555000.05621000.0743000.0-3561000.0-3264000.0-761000.02300000.0753000.0149000.051000.0260000.0-2072000.0358000.0364000.0708000.0527000.0297000.0833000.0159000.0231000.0104000.0-358000.0177000.038000.093000.0112000.0-118000.0219000.0614000.080000.0
Percentage of IncreaseDecreaseInOtherOperatingAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value-7.6885.457-1.5694.951-127.5110.637-0.324-2.8811292.7852.064-15.13214-1.381.944-0.157-2.8192.943-1.0760.26-0.9460.6630.3110.946-3.0150.782.0630.529-1.1940.23
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InterestAndOtherIncome

us-gaap:InterestAndOtherIncome


Interest
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value0.2741.4690.6443.1653.0524.1934.1254.1773.7723.0792.6462.0713.651.1061.0310.6450.2170.8660.1291.4160.1131.4580.7070.843
Percentage of InterestAndOtherIncome100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InvestmentIncomeNet us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:InvestmentIncomeNet

fgen:Falikang


Investment
Period End2020-09-30
Value2800000.0
Percentage of InvestmentIncomeNet100.0

us-gaap:LeaseCost

us-gaap:LeaseCost


Lease
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value3.4883.1192.8853.1043.1363.1263.1963.1383.1062.747
Percentage of LeaseCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeaseCost


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value1744000.0418000.0283000.0304000.0255000.0309000.0312000.0290000.0163000.0126000.0
Percentage of OperatingLeaseCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeasePayments

us-gaap:OperatingLeasePayments


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value1771000.0475000.0139000.0379000.0284000.0149000.0374000.0349000.092000.099000.0
Percentage of OperatingLeasePayments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value17000.0-55000.0-408000.0-657000.0-1129000.01649000.0-120000.0-385000.0655000.0442000.021000.0-31000.053000.0-50000.09000.0356000.0628000.0195000.0-605000.0-125000.0300000.0589000.0-486000.09000.0-393000.0706000.0-671000.0-232000.0-280000.0-540000.0
Percentage of OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value17000.0-55000.0-408000.0-657000.0-1129000.01649000.0-120000.0-385000.0655000.0442000.021000.0-31000.053000.0-50000.0
Percentage of OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value17000.0-55000.0-408000.0-657000.0-1129000.01649000.0-120000.0-385000.0655000.0442000.021000.0-31000.053000.0-50000.09000.0403000.0654000.0179000.0-605000.0-144000.0300000.0589000.0-504000.0191000.0-368000.0711000.087000.0-232000.0-280000.0-540000.0
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation

us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value1.1714.7572.4562.1491.5795.2792.1362.5492.0775.9882.3243.2833.1926.8132.3262.2971.2492.4240.4980.4510.531.2612.2430.00.00.0
Percentage of PaymentsRelatedToTaxWithholdingForShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

us-gaap:PaymentsToAcquireAvailableForSaleSecurities

us-gaap:PaymentsToAcquireAvailableForSaleSecurities


Payments
Period End2021-06-302021-03-312020-06-302020-03-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value701960.00.0381100.0540.0440.0670.0360.0360.038.9690.0260.0270.019338.2170.00.0144
Percentage of PaymentsToAcquireAvailableForSaleSecurities100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.0

us-gaap:PaymentsToAcquireBusinessesGross

us-gaap:PaymentsToAcquireBusinessesGross


Payments
Period End2020-09-30
Value0.726
Percentage of PaymentsToAcquireBusinessesGross100.0

us-gaap:PaymentsToAcquireBusinessesGross us-gaap:BusinessAcquisition, us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:FibroGenBeijing


Payments
Period End2020-07-31
Value15
Percentage of PaymentsToAcquireBusinessesGross0.0

us-gaap:ProceedsFromIssuanceOfCommonStock

us-gaap:ProceedsFromIssuanceOfCommonStock


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
Value5.6796.077119.7379.5067.0045.0682.3737.7655.5725.2497.2558.3848.9596.354169.1453.0993.7441.6413.2831.2134.2262.9154.8870.7210.7720.094
Percentage of ProceedsFromIssuanceOfCommonStock100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments

us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value100.0421551001564523220550507.036228.2117
Percentage of ProceedsFromSaleMaturityAndCollectionsOfInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities


Proceeds
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-31
Value0.00.00.0100.00.00.00.00.00.08.1670.00.02.9577.947100.04.2980.00.05.1880.0
Percentage of ProceedsFromSaleOfAvailableForSaleSecurities0.00.00.0100.00.00.00.00.00.00.0100.00.00.0100.0100.0100.00.0100.00.00.0100.00.0

us-gaap:ProceedsFromSaleOfEquityMethodInvestments us-gaap:SubsequentEventType

us-gaap:ProceedsFromSaleOfEquityMethodInvestments

us-gaap:SubsequentEvent


Proceeds
Period End2020-10-31
Value7300000.0
Percentage of ProceedsFromSaleOfEquityMethodInvestments100.0

us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty

fgen:Astellas, us-gaap:CollaborativeArrangement


Related
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
Value0.10.00.20.20.10.60.90.80.50.40.40.20.60.20.20.30.31.61.81.41.62.03.41.33.04.32.6
Percentage of RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations

us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations


Repayments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value100000.0101000.0101000.0101000.0100000.0101000.0101000.0100000.0101000.0101000.0101000.0101000.0100000.0101000.0
Percentage of RepaymentsOfDebtAndCapitalLeaseObligations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueFromRelatedParties us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TransactionType

us-gaap:RevenueFromRelatedParties

fgen:Astellas, fgen:APIShipment


Revenue
Period End2020-09-30
Value-4.0
Percentage of RevenueFromRelatedParties100.0

us-gaap:RevenueFromRelatedParties us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

fgen:Astellas, us-gaap:CollaborativeArrangement


Revenue
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
Value2.63.64.74.84.7-32.5151344.9695.1205.24.04.64.73.64.04.8133.74.76.05.65.35.54.4
Percentage of RevenueFromRelatedParties0.00.0-117.50.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

fgen:Falikang, us-gaap:CollaborativeArrangement


Revenue
Period End2021-06-302021-03-31
Value1110
Percentage of RevenueFromRelatedParties0.00.0

us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability


Right
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value-0.0190.3220.2280.290.1350.0090.1250.1080.07849
Percentage of RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability


Right
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value36000.03462000.01017000.050000.05000.0013000.01511000.0482000.0730000.0
Percentage of RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability100.0100.0100.0100.0100.00.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value63.458.8-0.659.00.6920.6830.0010.6780.6820.6790.0010.6810.6750.67900.6950.710.717-0.0010.730.720.69-0.0010.70.70.7-0.0020.6300
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value0.90.700.30.0040.00900.0170.020.02600.0290.0280.02700.0190.0190.02300.0120.0130.01400.0170.0170.01400.01700
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.00.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value11.9127.460.2522.4821.7217.24-0.4625.1724.434.14-0.2535.9931.3532.180.3326.4717.0616.160.0310.7311.611.46-0.0913.4712.2717.490.299.2200
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:StockCompensationPlan


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-30
Value13.616.94-0.2117.017.8218.57-0.2619.2719.0720.571.020.115.2510.930.269.679.18.86-0.339.0410.0612.80.7909.7513.2713.2200
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue114.261.7-84.075.682.0107.756.576.678.260.3-400.055.848.634.078.836.553.354.8-1100.084.286.7111.7-877.80.079.575.94558.60.00.0

us-gaap:SubleaseIncome

us-gaap:SubleaseIncome


Sublease
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value275000.0300000.0302000.0301000.0306000.0292000.0250000.0310000.0237000.0588000.0
Percentage of SubleaseIncome100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:VariableInterestEntityOwnershipPercentage us-gaap:BusinessAcquisition, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:VariableInterestEntityOwnershipPercentage

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:AstraZenecaAB, fgen:FibroGenBeijing


Variable
Period End2020-09-15
Value51.1
Percentage of VariableInterestEntityOwnershipPercentage100.0

us-gaap:VariableInterestEntityOwnershipPercentage us-gaap:BusinessAcquisition, us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:AstraZenecaAB, fgen:FibroGenBeijing


Variable
Period End2020-09-15
Value51.1
Percentage of VariableInterestEntityOwnershipPercentage100.0

us-gaap:VariableInterestEntityOwnershipPercentage us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:Falikang


Variable
Period End2020-09-30
Value51.1
Percentage of VariableInterestEntityOwnershipPercentage0.0

us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment

us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment


Weighted
Period End2020-09-302020-06-302019-09-302019-06-302018-09-302018-06-30
Value3120000.0005283000.000
Percentage of WeightedAverageNumberDilutedSharesOutstandingAdjustment100.00.00.0100.00.00.0

fgen:AccruedActivePharmaceuticalIngredientProductPriceAdjustmentCurrent

fgen:AccruedActivePharmaceuticalIngredientProductPriceAdjustmentCurrent


Accrued
Period End2020-09-302020-06-302020-03-312019-12-312018-12-31
Value3.9570.00.0360.0
Percentage of AccruedActivePharmaceuticalIngredientProductPriceAdjustmentCurrent100.00.00.0100.00.0

fgen:AccruedCoPromotionExpensesCurrent

fgen:AccruedCoPromotionExpensesCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-30
Value20171114
Percentage of AccruedCoPromotionExpensesCurrent100.0100.0100.0100.0

fgen:AccruedContractLiabilitiesToPharmaceuticalDistributorsCurrent

fgen:AccruedContractLiabilitiesToPharmaceuticalDistributorsCurrent


Accrued
Period End2021-06-302021-03-312020-12-31
Value131515
Percentage of AccruedContractLiabilitiesToPharmaceuticalDistributorsCurrent100.0100.0100.0

fgen:AccruedLongTermCoPromotionLiabilityCurrent

fgen:AccruedLongTermCoPromotionLiabilityCurrent


Accrued
Period End2020-12-312020-09-30
Value1114
Percentage of AccruedLongTermCoPromotionLiabilityCurrent100.0100.0

fgen:AccruedLongTermCoPromotionLiabilityCurrent us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

us-gaap:AccountsPayable, fgen:AstraZenecaAgreements


Accrued
Period End2020-12-31
Value16
Percentage of AccruedLongTermCoPromotionLiabilityCurrent147.0

us-gaap:AccruedLiabilities, fgen:AstraZenecaAgreements


Accrued
Period End2020-12-31
Value0.0115
Percentage of AccruedLongTermCoPromotionLiabilityCurrent0.1

fgen:AccruedLongTermCoPromotionLiabilityCurrent us-gaap:TypeOfArrangement

fgen:AstraZenecaAgreements


Accrued
Period End2020-09-30
Value14
Percentage of AccruedLongTermCoPromotionLiabilityCurrent100.0

fgen:AccruedLongTermCoPromotionLiabilityNonCurrent

fgen:AccruedLongTermCoPromotionLiabilityNonCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value1923272653
Percentage of AccruedLongTermCoPromotionLiabilityNonCurrent100.0100.0100.0100.0100.0

fgen:AccruedLongTermCoPromotionLiabilityNonCurrent us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

us-gaap:OtherNoncurrentLiabilities, fgen:AstraZenecaAgreements


Accrued
Period End2020-12-312020-09-30
Value2726
Percentage of AccruedLongTermCoPromotionLiabilityNonCurrent99.999.8

fgen:AccruedLongTermCoPromotionalLiabilityNonCurrent us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

fgen:AccruedLongTermCoPromotionalLiabilityNonCurrent

us-gaap:OtherNoncurrentLiabilities, fgen:AstraZenecaAgreements


Accrued
Period End2020-12-31
Value27
Percentage of AccruedLongTermCoPromotionalLiabilityNonCurrent100.0

fgen:AccruedLongTermCoPromotionalLiabilityNonCurrent us-gaap:StatementScenario, us-gaap:TypeOfArrangement

srt:ScenarioForecast, fgen:AstraZenecaAgreements


Accrued
Period End2020-09-30
Value82
Percentage of AccruedLongTermCoPromotionalLiabilityNonCurrent0.0

fgen:AccruedPreclinicalAndClinicalTrialCurrent

fgen:AccruedPreclinicalAndClinicalTrialCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value653944292116164141413522233732262831293032292724322625
Percentage of AccruedPreclinicalAndClinicalTrialCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:AccruedProductDevelopmentCosts

fgen:AccruedProductDevelopmentCosts


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value181718171616161616161616161717161615141515151515151416
Percentage of AccruedProductDevelopmentCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:AccruedProductDevelopmentCostsExcludingInterest

fgen:AccruedProductDevelopmentCostsExcludingInterest


Accrued
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value111010119.91011
Percentage of AccruedProductDevelopmentCostsExcludingInterest100.0100.0100.0100.0100.0100.0100.0

fgen:AvailableForSaleSecuritiesBondAndMutualFundsMaturingWithinOneYear

fgen:AvailableForSaleSecuritiesBondAndMutualFundsMaturingWithinOneYear


Available
Period End2020-12-31
Value8144000.0
Percentage of AvailableForSaleSecuritiesBondAndMutualFundsMaturingWithinOneYear100.0

fgen:CashConsiderationReceivedUnderCollaborationAgreement us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:CashConsiderationReceivedUnderCollaborationAgreement

fgen:ChinaPerformanceObligation, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value171153137142141141140137136127125119115
Percentage of CashConsiderationReceivedUnderCollaborationAgreement100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:CoDevelopmentInformationSharingAndCommitteeServices, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value585570557539526514501479467444429406386366
Percentage of CashConsiderationReceivedUnderCollaborationAgreement340.3372.1405.6378.2371.4363.8355.9349.3342.5347.3341.0339.8333.30.0

fgen:DevelopmentAndOtherRevenue, country:JP, fgen:AstellasCollaborationAgreement


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value161616151515151514141413
Percentage of CashConsiderationReceivedUnderCollaborationAgreement9.610.812.011.011.011.011.011.210.711.211.311.7

fgen:DevelopmentAndOtherRevenue, srt:Europe, fgen:AstellasCollaborationAgreement


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value255253250246242239235231226209206203
Percentage of CashConsiderationReceivedUnderCollaborationAgreement148.5165.3182.3173.2171.2169.1167.3168.4165.7163.9163.7169.6

us-gaap:License, country:JP, fgen:AstellasCollaborationAgreement


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value100100100868686868674747474
Percentage of CashConsiderationReceivedUnderCollaborationAgreement58.465.573.160.360.760.961.062.654.257.958.961.9

us-gaap:License, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value341341341341341341341327327294294286
Percentage of CashConsiderationReceivedUnderCollaborationAgreement198.8223.1248.9239.8241.3241.9242.5238.3239.6229.9233.7239.0

us-gaap:License, srt:Europe, fgen:AstellasCollaborationAgreement


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value487487487487487487487487487370370370
Percentage of CashConsiderationReceivedUnderCollaborationAgreement283.8318.5355.3342.3344.5345.3346.2355.3357.3289.5294.4309.4

fgen:CashConsiderationReceivedUnderCollaborationAgreement us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

country:JP, fgen:AstellasCollaborationAgreement


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value116116116101101101101101888888888772494848484747444444444343
Percentage of CashConsiderationReceivedUnderCollaborationAgreement68.076.385.171.471.871.972.073.865.069.170.273.575.60.00.00.00.00.00.00.00.00.00.00.00.00.0

fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value10981065103610231009997984944931866849812788764
Percentage of CashConsiderationReceivedUnderCollaborationAgreement639.1695.3754.5718.0712.7705.7698.4687.6682.1677.2674.8678.9680.20.0

srt:Europe, fgen:AstellasCollaborationAgreement


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value743741738734730726723719714580576573
Percentage of CashConsiderationReceivedUnderCollaborationAgreement432.4483.8537.6515.5515.7514.4513.4523.7523.0453.4458.1479.0

fgen:CollaborativeArrangementAggregateConsideration us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:CollaborativeArrangementAggregateConsideration

country:CN, fgen:AstraZenecaAgreements


Collaborative
Period End2020-12-312020-06-302020-03-312019-12-312019-09-302019-06-30
Value777777555555
Percentage of CollaborativeArrangementAggregateConsideration100.0100.0100.0100.0100.0100.0

country:JP, fgen:AstellasCollaborationAgreement


Collaborative
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value90900.0901907777
Percentage of CollaborativeArrangementAggregateConsideration0.0116.70.1163.2140.6140.6

fgen:UnitedStatesAndRestOfWorld, fgen:AstraZenecaAgreements


Collaborative
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value439439389389389389
Percentage of CollaborativeArrangementAggregateConsideration0.0568.7503.9704.7704.7704.7

srt:Europe, fgen:AstellasCollaborationAgreement


Collaborative
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value540540410410410410
Percentage of CollaborativeArrangementAggregateConsideration0.0699.5531.1742.8742.8742.8

fgen:CollaborativeArrangementAggregateConsiderationForMilestoneAndUpfrontPayments us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType, us-gaap:SubsequentEventType

fgen:CollaborativeArrangementAggregateConsiderationForMilestoneAndUpfrontPayments

fgen:LicenseAgreementWithEluminex, us-gaap:SubsequentEvent


Collaborative
Period End2021-07-19
Value8.0
Percentage of CollaborativeArrangementAggregateConsiderationForMilestoneAndUpfrontPayments100.0

fgen:CommonStockSharesReserved

fgen:CommonStockSharesReserved


Common
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value1141101051018481
Percentage of CommonStockSharesReserved100.0100.0100.0100.0100.0100.0

fgen:ContractWithCustomerLiabilityGross us-gaap:ProductOrService

fgen:ContractWithCustomerLiabilityGross

us-gaap:Product


Contract
Period End2020-12-312020-09-30
Value-15685000.0-11392000.0
Percentage of ContractWithCustomerLiabilityGross100.0100.0

fgen:ContractWithCustomerLiabilityNetOfAccountsReceivable us-gaap:ProductOrService

fgen:ContractWithCustomerLiabilityNetOfAccountsReceivable

us-gaap:Product


Contract
Period End2020-12-312020-09-30
Value548000.09759000.0
Percentage of ContractWithCustomerLiabilityNetOfAccountsReceivable100.0100.0

fgen:CorporateBondsAtCarryingValue

fgen:CorporateBondsAtCarryingValue


Corporate
Period End2021-03-31
Value9085000.0
Percentage of CorporateBondsAtCarryingValue100.0

fgen:CumulativeRevenueLicenseAndDevelopmentRevenueRecognized us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:CumulativeRevenueLicenseAndDevelopmentRevenueRecognized

fgen:ChinaPerformanceObligation, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cumulative
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value22101.390.6840.2430.090.0190.00.00.00.00.0
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.0

fgen:CoDevelopmentInformationSharingAndCommitteeServices, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value582565554536521507493468451427408377353330
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized2628.95436.80.038618.176253.2208980.2548073.32465836.80.00.00.00.00.00.0

fgen:DevelopmentAndOtherRevenue, country:JP, fgen:AstellasCollaborationAgreement


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value161616151515151514141313
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized74.6157.90.01118.22259.96293.416811.179263.20.00.00.00.0

fgen:DevelopmentAndOtherRevenue, srt:Europe, fgen:AstellasCollaborationAgreement


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value255252248244240235231227224207202198
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized1150.52426.40.017614.035114.696947.3256675.61196315.80.00.00.00.0

us-gaap:License, country:JP, fgen:AstellasCollaborationAgreement


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value100100100868686868674747474
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized452.7964.30.06188.812576.635400.895582.2452757.90.00.00.00.0

us-gaap:License, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value341341341341341341341327327294294286
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized1542.13285.10.024593.149977.2140676.5379826.71722500.00.00.00.00.0

us-gaap:License, srt:Europe, fgen:AstellasCollaborationAgreement


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value487487487487487487487487487370370370
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized2201.24689.10.035104.471337.9200802.9542167.82568163.20.00.00.00.0

fgen:CumulativeRevenueLicenseAndDevelopmentRevenueRecognized us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

country:JP, fgen:AstellasCollaborationAgreement


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value116116116101101101101101888887878771
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized527.31122.20.07307.014836.541694.2112393.3532021.10.00.00.00.00.00.0

fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value946918896880864849835795778721702663640616
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized4271.08821.80.063311.2126330.4349756.8928000.04188436.80.00.00.00.00.00.0

srt:Europe, fgen:AstellasCollaborationAgreement


Cumulative
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value742740736732728723718715712577573569
Percentage of CumulativeRevenueLicenseAndDevelopmentRevenueRecognized3351.87115.50.052718.3106452.5297750.2798843.33764478.90.00.00.00.0

fgen:DeferredTaxAssetsIntangibleAssets

fgen:DeferredTaxAssetsIntangibleAssets


Deferred
Period End2020-12-31
Value75
Percentage of DeferredTaxAssetsIntangibleAssets100.0

fgen:DeferredTaxLiabilitiesFixedAssets

fgen:DeferredTaxLiabilitiesFixedAssets


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value5073000.08266000.00181000.0122000.0853000.01266000.0
Percentage of DeferredTaxLiabilitiesFixedAssets100.0100.00.0100.0100.0100.0100.0

fgen:DueToRelatedPartiesDeferredRevenueCurrent

fgen:DueToRelatedPartiesDeferredRevenueCurrent


Due
Period End2021-06-302021-03-312020-12-312019-12-31
Value104.0052.9070.249
Percentage of DueToRelatedPartiesDeferredRevenueCurrent100.0100.0100.0100.0

fgen:DueToRelatedPartiesDeferredRevenueNoncurrent

fgen:DueToRelatedPartiesDeferredRevenueNoncurrent


Due
Period End2021-06-302021-03-312020-12-312019-12-31
Value9.381144.6360.125
Percentage of DueToRelatedPartiesDeferredRevenueNoncurrent100.0100.0100.0100.0

fgen:EquityMethodInvestmentInUnconsolidatedVariableInterestEntity

fgen:EquityMethodInvestmentInUnconsolidatedVariableInterestEntity


Equity
Period End2021-06-302021-03-312020-12-31
Value3083000.02483000.02728000.0
Percentage of EquityMethodInvestmentInUnconsolidatedVariableInterestEntity100.0100.0100.0

fgen:FinanceLeaseAccumulatedAmortization

fgen:FinanceLeaseAccumulatedAmortization


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value1.146232018151210
Percentage of FinanceLeaseAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0

fgen:FinanceLeaseAndOperatingLeaseAssets

fgen:FinanceLeaseAndOperatingLeaseAssets


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value97323133353841
Percentage of FinanceLeaseAndOperatingLeaseAssets100.0100.0100.0100.0100.0100.0100.0

fgen:FinanceLeaseAndOperatingLeaseLiability

fgen:FinanceLeaseAndOperatingLeaseLiability


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value104393942454851
Percentage of FinanceLeaseAndOperatingLeaseLiability100.0100.0100.0100.0100.0100.0100.0

fgen:FinanceLeaseRightOfUseAssetsCost

fgen:FinanceLeaseRightOfUseAssetsCost


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value2.007505050494949
Percentage of FinanceLeaseRightOfUseAssetsCost100.0100.0100.0100.0100.0100.0100.0

fgen:LeaseObligationsNoncurrent

fgen:LeaseObligationsNoncurrent


Lease
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value0.8390.941.041.1411.2421.3421.44397
Percentage of LeaseObligationsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0

fgen:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour

fgen:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour


Lessee
Period End2021-06-302021-03-31
Value530.065
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour100.0100.0

fgen:MiscellaneousReceivables us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:MiscellaneousReceivables

fgen:Falikang


Miscellaneous
Period End2021-03-312020-12-312020-09-30
Value1000000.0900000.0200000.0
Percentage of MiscellaneousReceivables100.0100.0100.0

fgen:OperatingLeaseAccumulatedAmortization

fgen:OperatingLeaseAccumulatedAmortization


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value3614000.02264000.01891000.01554000.01270000.01078000.0805000.0
Percentage of OperatingLeaseAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0

fgen:OperatingLeaseRightOfUseAssetsCost

fgen:OperatingLeaseRightOfUseAssetsCost


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value1007.343.9342.7962.6472.7362.736
Percentage of OperatingLeaseRightOfUseAssetsCost100.0100.0100.0100.0100.0100.0100.0

fgen:PercentageOfPreLaunchInventoryCapitalizedOfAggregateInventoryBalance

fgen:PercentageOfPreLaunchInventoryCapitalizedOfAggregateInventoryBalance


Percentage
Period End2021-06-302021-03-312020-12-31
Value37.037.029.0
Percentage of PercentageOfPreLaunchInventoryCapitalizedOfAggregateInventoryBalance100.0100.0100.0

fgen:PropertyTaxesAndOtherCurrent

fgen:PropertyTaxesAndOtherCurrent


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
Value109.2425.976.0571.1454.0332.0442.3891.7782.9691.0951.91.8433.154.2010.451
Percentage of PropertyTaxesAndOtherCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:RestrictedTimeDepositsNoncurrent

fgen:RestrictedTimeDepositsNoncurrent


Restricted
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-31
Value2072000.02072000.02072000.02072000.02072000.02072000.02072000.04145000.04145000.04145000.04145000.05181000.05181000.05181000.05181000.06217000.06217000.06217000.06217000.07254000.0
Percentage of RestrictedTimeDepositsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

fgen:RoyaltyRateOnNetRevenue us-gaap:TypeOfArrangement

fgen:RoyaltyRateOnNetRevenue

fgen:AstraZenecaAgreements


Royalty
Period End2020-12-31
Value40.0
Percentage of RoyaltyRateOnNetRevenue100.0

fgen:SuppliesNet

fgen:SuppliesNet


Supplies
Period End2021-03-312020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Value4.030.01261251261270.0
Percentage of SuppliesNet100.00.0100.0100.0100.0100.00.0

fgen:SuppliesNet us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:UnitedStatesAndRestOfWorld, fgen:AstraZenecaAgreements


Supplies
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-30
Value5.33.72.1505050
Percentage of SuppliesNet0.091.80.039.939.739.1

fgen:SuppliesNet us-gaap:TypeOfArrangement

fgen:AstraZenecaAgreements


Supplies
Period End2021-06-302021-03-31
Value5.33.7
Percentage of SuppliesNet0.091.8

fgen:TransactionPriceAllocatedToPerformanceObligations us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:TransactionPriceAllocatedToPerformanceObligations

country:JP, fgen:AstellasCollaborationAgreement


Transaction
Period End2020-12-312019-09-30
Value1512
Percentage of TransactionPriceAllocatedToPerformanceObligations100.0100.0

us-gaap:AccountsPayableRelatedPartiesCurrent

us-gaap:AccountsPayableRelatedPartiesCurrent


Accounts
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302018-12-31
Value001118000.00730000.00
Percentage of AccountsPayableRelatedPartiesCurrent0.00.0100.00.0100.00.0

us-gaap:AccountsReceivableRelatedPartiesCurrent

us-gaap:AccountsReceivableRelatedPartiesCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value13324.1274.715123.7234.845174.3113.8984719254.4524.0044.584.7393.6044.1024.816133.6624.4555.461105.2785.033
Percentage of AccountsReceivableRelatedPartiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccountsReceivableRelatedPartiesCurrent us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:Falikang


Accounts
Period End2021-06-302021-03-31
Value1015
Percentage of AccountsReceivableRelatedPartiesCurrent80.946.9

us-gaap:AccountsReceivableRelatedPartiesCurrent us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

fgen:Astellas, us-gaap:CollaborativeArrangement


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value2.6174.14.7123.74.8174.33.94719254.54.04.64.73.64.14.8133.74.55.55.0
Percentage of AccountsReceivableRelatedPartiesCurrent19.553.399.399.7100.199.499.1100.299.7100.1100.099.8100.1101.199.9100.499.299.9100.099.7100.3101.0101.0100.799.3

us-gaap:AccruedLiabilitiesAndOtherLiabilities

us-gaap:AccruedLiabilitiesAndOtherLiabilities


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1471191199050428370666666
Percentage of AccruedLiabilitiesAndOtherLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccruedProfessionalFeesCurrent

us-gaap:AccruedProfessionalFeesCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value7471000.05948000.04869000.07384000.05653000.04608000.04842000.04063000.03588000.03547000.02648000.01835000.02370000.02520000.01991000.02144000.01653000.01434000.01252000.01730000.01041000.01338000.01662000.01764000.01121000.03271000.02401000.0
Percentage of AccruedProfessionalFeesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivable us-gaap:ProductOrService

us-gaap:AllowanceForDoubtfulAccountsReceivable

us-gaap:Product


Allowance
Period End2020-12-312020-09-302020-06-302020-03-312019-12-31
Value0.89.9145.7241.5191.102
Percentage of AllowanceForDoubtfulAccountsReceivable100.0100.0100.0100.0100.0

us-gaap:AllowanceForDoubtfulAccountsReceivable us-gaap:ProductOrService, us-gaap:EquityMethodInvestmentNonconsolidatedInvestee

us-gaap:Product, fgen:BeijingFalikangPharmaceuticalCoLtd


Allowance
Period End2021-06-302021-03-31
Value109.2
Percentage of AllowanceForDoubtfulAccountsReceivable0.00.0

us-gaap:AllowanceForDoubtfulAccountsReceivable us-gaap:ProductOrService, us-gaap:ValuationAllowancesAndReservesType

us-gaap:Product, fgen:ContractualSalesRebate


Allowance
Period End2020-09-302020-06-302020-03-312019-12-31
Value3.4791.8780.5240.148
Percentage of AllowanceForDoubtfulAccountsReceivable35.132.834.513.4

us-gaap:Product, fgen:NonKeyAccountHospitalListingAward


Allowance
Period End2020-09-302020-06-302019-12-31
Value5.2382.5670.0
Percentage of AllowanceForDoubtfulAccountsReceivable52.844.80.0

us-gaap:Product, fgen:OtherDiscountsAndRebates


Allowance
Period End2020-09-302020-06-302019-12-31
Value0.5130.260.018
Percentage of AllowanceForDoubtfulAccountsReceivable5.24.51.6

us-gaap:Product, fgen:PriceAdjustment


Allowance
Period End2020-09-302020-06-302020-03-312019-12-31
Value0.5290.9350.9360.936
Percentage of AllowanceForDoubtfulAccountsReceivable5.316.361.684.9

us-gaap:Product, fgen:ProvisionForCreditLoss


Allowance
Period End2020-09-302020-06-302019-12-31
Value0.1020.0840.0
Percentage of AllowanceForDoubtfulAccountsReceivable1.01.50.0

us-gaap:Product, us-gaap:SalesReturnsAndAllowances


Allowance
Period End2020-09-30
Value0.053
Percentage of AllowanceForDoubtfulAccountsReceivable0.5

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AssetsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value267312590577406375444343395364303505590608588564117
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value2152248.144308011011020523526033411528365376127
Percentage of AssetsFairValueDisclosure80.671.91.45.219.729.424.859.859.571.3110.322.94.86.09.213.6108.9

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value482537598607487486554548630625638621618644642641244
Percentage of AssetsFairValueDisclosure180.6171.9101.4105.2119.7129.4124.8159.8159.5171.3210.3122.9104.8106.0109.2113.6208.9

us-gaap:AvailableForSaleSecurities

us-gaap:AvailableForSaleSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value2592048.38815525641446844359761558712638557295108125150142151154159140150153158
Percentage of AvailableForSaleSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecurities us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring, fgen:BondAndMutualFunds


Available
Period End2021-06-302021-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value0.00.01010101010101018181822
Percentage of AvailableForSaleSecurities0.00.02.32.41.81.71.88.326.833.725.419.114.9

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring, fgen:USGovernmentBonds


Available
Period End2021-06-302021-03-31
Value4630
Percentage of AvailableForSaleSecurities17.914.7

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring, us-gaap:EquitySecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value0.2330.2420.2440.2470.2290.2230.2550.2510.2370.2460.2340.2230.210.1990.2210.2070.225
Percentage of AvailableForSaleSecurities0.10.12.90.20.10.10.10.10.00.00.00.20.50.40.30.20.1

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring, us-gaap:USTreasurySecurities


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value125176303347226350344292
Percentage of AvailableForSaleSecurities80.668.673.274.151.158.856.049.7

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, fgen:AgencyBonds


Available
Period End2021-06-302021-03-31
Value1414
Percentage of AvailableForSaleSecurities5.57.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, fgen:BondAndMutualFunds


Available
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value0.00.08.1440.00.00.00.00.00.00.00.00.00.00.0
Percentage of AvailableForSaleSecurities0.00.097.10.00.00.00.00.00.00.00.00.00.00.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:AssetBackedSecurities


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecurities4.86.1

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:CertificatesOfDeposit


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-09-302016-12-31
Value30303030303029291091.0361.037
Percentage of AvailableForSaleSecurities19.311.77.36.46.85.04.95.186.81.10.7

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:CommercialPaper


Available
Period End2021-06-302021-03-31
Value72100
Percentage of AvailableForSaleSecurities27.849.4

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:CorporateBondSecurities


Available
Period End2021-06-302021-03-31
Value10484
Percentage of AvailableForSaleSecurities40.241.4

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:ForeignGovernmentDebt


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecurities4.76.0

us-gaap:AvailableForSaleSecurities us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueMeasurementsRecurring, fgen:AgencyBonds


Available
Period End2021-06-302021-03-31
Value1414
Percentage of AvailableForSaleSecurities5.57.0

us-gaap:FairValueMeasurementsRecurring, fgen:BondAndMutualFunds


Available
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value0.00.08.1441010101010101018181822
Percentage of AvailableForSaleSecurities0.00.097.12.32.41.81.71.88.326.833.725.419.114.9

us-gaap:FairValueMeasurementsRecurring, fgen:USGovernmentBonds


Available
Period End2021-06-302021-03-31
Value4630
Percentage of AvailableForSaleSecurities17.914.7

us-gaap:FairValueMeasurementsRecurring, us-gaap:AssetBackedSecurities


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecurities4.86.1

us-gaap:FairValueMeasurementsRecurring, us-gaap:CertificatesOfDeposit


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-09-302016-12-31
Value30303030303029291091.0361.037
Percentage of AvailableForSaleSecurities19.311.77.36.46.85.04.95.186.81.10.7

us-gaap:FairValueMeasurementsRecurring, us-gaap:CommercialPaper


Available
Period End2021-06-302021-03-31
Value72100
Percentage of AvailableForSaleSecurities27.849.4

us-gaap:FairValueMeasurementsRecurring, us-gaap:CorporateBondSecurities


Available
Period End2021-06-302021-03-31
Value10484
Percentage of AvailableForSaleSecurities40.241.4

us-gaap:FairValueMeasurementsRecurring, us-gaap:EquitySecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value0.2330.2420.2440.2470.2290.2230.2550.2510.2370.2460.2340.2230.210.1990.2210.2070.225
Percentage of AvailableForSaleSecurities0.10.12.90.20.10.10.10.10.00.00.00.20.50.40.30.20.1

us-gaap:FairValueMeasurementsRecurring, us-gaap:ForeignGovernmentDebt


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecurities4.76.0

us-gaap:FairValueMeasurementsRecurring, us-gaap:USTreasurySecurities


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value125226383427402476495517
Percentage of AvailableForSaleSecurities80.688.292.791.290.779.780.488.0

us-gaap:AvailableForSaleSecurities us-gaap:InvestmentType

fgen:BondAndMutualFunds


Available
Period End2020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value8.1441010101010101018181820222223252525
Percentage of AvailableForSaleSecurities97.12.32.41.81.71.88.326.833.725.419.119.218.014.916.316.816.615.7

us-gaap:AssetBackedSecurities


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecurities4.86.1

us-gaap:Bonds


Available
Period End2021-06-302021-03-31
Value1414
Percentage of AvailableForSaleSecurities5.57.0

us-gaap:CertificatesOfDeposit


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-09-30
Value30303030303029291091.0361.0361.0361.0372.2418.2158.222
Percentage of AvailableForSaleSecurities19.311.77.36.46.85.04.95.186.81.11.00.80.71.55.15.8

us-gaap:CommercialPaper


Available
Period End2021-06-302021-03-31
Value6959
Percentage of AvailableForSaleSecurities26.729.1

us-gaap:CorporateBondSecurities


Available
Period End2021-06-302021-03-31
Value10475
Percentage of AvailableForSaleSecurities40.236.9

us-gaap:EquitySecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value0.2330.2420.2440.2470.2290.2230.2550.2510.2370.2460.2340.2230.210.1990.2210.2070.1870.2050.2250.220.2370.2310.1970.1860.1990.2090.201
Percentage of AvailableForSaleSecurities0.10.12.90.20.10.10.10.10.00.00.00.20.50.40.30.20.20.20.10.20.20.10.10.10.10.10.1

us-gaap:ForeignGovernmentDebt


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecurities4.76.0

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-31
Value4630
Percentage of AvailableForSaleSecurities17.914.7

us-gaap:USTreasurySecurities


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value125226383427402476495467
Percentage of AvailableForSaleSecurities80.688.292.791.290.779.780.479.5

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value146000.0129000.0119000.0527000.01304000.02729000.0784000.0894000.01236000.0695000.0238000.0145000.0120000.01412000.01252000.01212000.0872000.0431000.0439000.0794000.01024000.0634000.0125000.0383000.0362000.0865000.0331000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax us-gaap:InvestmentType

us-gaap:AssetBackedSecurities


Available
Period End2021-06-30
Value1000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax0.7

us-gaap:Bonds


Available
Period End2021-06-302021-03-31
Value2000.01000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax1.40.8

us-gaap:CertificatesOfDeposit


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-09-30
Value10000.0138000.0115000.032000.0021000.00000000005000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax1.910.64.24.10.01.70.00.00.00.00.00.00.00.00.01.3

us-gaap:CommercialPaper


Available
Period End2021-03-31
Value4000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax3.1

us-gaap:CorporateBondSecurities


Available
Period End2021-06-302021-03-31
Value27000.04000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax18.53.1

us-gaap:EquitySecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value115000.0117000.0119000.0122000.0104000.098000.0130000.0126000.0112000.0121000.0109000.098000.084000.074000.095000.081000.061000.079000.0100000.095000.0112000.0105000.071000.062000.075000.084000.077000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax78.890.7100.023.18.03.616.614.19.117.445.867.670.05.27.66.77.018.322.812.010.916.656.816.220.79.723.3

us-gaap:USTreasuryAndGovernment


Available
Period End2021-03-31
Value2000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax1.6

us-gaap:USTreasurySecurities


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value395000.01062000.02516000.0536000.0688000.01028000.0516000.0109000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax75.081.492.268.477.083.274.245.8

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax


Available
Period End2021-06-302021-03-312020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value71000.067000.03000.00025000.025000.004000.0159000.069000.038000.092000.046000.016000.028000.0216000.049000.07000.05000.075000.0475000.0179000.0166000.074000.0514000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax100.0100.0100.00.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax us-gaap:InvestmentType

fgen:BondAndMutualFunds


Available
Period End2020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value3000.000000000000175000.000000
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax100.00.00.00.00.00.00.00.00.00.00.00.081.00.00.00.00.00.0

us-gaap:AssetBackedSecurities


Available
Period End2021-03-31
Value4000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax6.0

us-gaap:Bonds


Available
Period End2021-06-302021-03-31
Value6000.03000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax8.54.5

us-gaap:CommercialPaper


Available
Period End2021-03-31
Value1000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax1.5

us-gaap:CorporateBondSecurities


Available
Period End2021-06-302021-03-31
Value43000.054000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax60.680.6

us-gaap:ForeignGovernmentDebt


Available
Period End2021-06-302021-03-31
Value1000.02000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax1.43.0

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-31
Value21000.03000.0
Percentage of AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax29.64.5

us-gaap:AvailableForSaleSecuritiesAmortizedCost

us-gaap:AvailableForSaleSecuritiesAmortizedCost


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value2592048.27215525541146744259561558712638537194107125150141150153159140150153158
Percentage of AvailableForSaleSecuritiesAmortizedCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesAmortizedCost us-gaap:InvestmentType

fgen:BondAndMutualFunds


Available
Period End2020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value8.1471010101010101017171720222223252525
Percentage of AvailableForSaleSecuritiesAmortizedCost98.52.32.41.81.71.88.226.832.124.218.218.718.114.916.316.816.715.7

us-gaap:AssetBackedSecurities


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecuritiesAmortizedCost4.86.2

us-gaap:Bonds


Available
Period End2021-06-302021-03-31
Value1414
Percentage of AvailableForSaleSecuritiesAmortizedCost5.57.0

us-gaap:CertificatesOfDeposit


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-09-302017-06-302017-03-312016-12-312016-03-312015-12-312015-09-30
Value30303030303030301101.0361.0361.0361.0372.2418.2178.217
Percentage of AvailableForSaleSecuritiesAmortizedCost19.311.87.36.46.85.04.95.186.91.11.00.80.71.55.15.8

us-gaap:CommercialPaper


Available
Period End2021-06-302021-03-31
Value6959
Percentage of AvailableForSaleSecuritiesAmortizedCost26.729.1

us-gaap:CorporateBondSecurities


Available
Period End2021-06-302021-03-31
Value10475
Percentage of AvailableForSaleSecuritiesAmortizedCost40.336.9

us-gaap:EquitySecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value0.1180.1250.1250.1250.1250.1250.1250.1250.1250.1250.1250.1250.1260.1250.1260.1260.1260.1260.1250.1250.1250.1260.1260.1240.1240.1250.124
Percentage of AvailableForSaleSecuritiesAmortizedCost0.00.11.50.10.00.00.00.00.00.00.00.10.30.20.20.10.10.10.10.10.10.10.10.10.10.10.1

us-gaap:ForeignGovernmentDebt


Available
Period End2021-06-302021-03-31
Value1212
Percentage of AvailableForSaleSecuritiesAmortizedCost4.76.0

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-31
Value4630
Percentage of AvailableForSaleSecuritiesAmortizedCost18.014.7

us-gaap:USTreasurySecurities


Available
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value124225381426401475494467
Percentage of AvailableForSaleSecuritiesAmortizedCost80.688.292.791.390.879.780.479.5

us-gaap:AvailableForSaleSecuritiesEquitySecurities

us-gaap:AvailableForSaleSecuritiesEquitySecurities


Available
Period End2020-12-31
Value244000.0
Percentage of AvailableForSaleSecuritiesEquitySecurities100.0

us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts us-gaap:BusinessAcquisition, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts

fgen:BeijingKangdaYongfuPharmaceuticalCoLTD, fgen:FibroGenBeijing


Business
Period End2020-07-31
Value5000000.0
Percentage of BusinessAcquisitionCostOfAcquiredEntityTransactionCosts100.0

us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired

fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:FibroGenBeijing


Business
Period End2020-12-31
Value48.9
Percentage of BusinessAcquisitionPercentageOfVotingInterestsAcquired100.0

us-gaap:Capital us-gaap:EquityMethodInvestmentNonconsolidatedInvestee, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:Capital

fgen:BeijingFalikangPharmaceuticalCoLtd, fgen:FibroGenBeijing


Capitalus-gaap:
Period End2020-12-31
Value17
Percentage of Capital100.0

us-gaap:CashAndCashEquivalentsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:CashAndCashEquivalentsFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring, us-gaap:MoneyMarketFunds


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value2202825904512307285105339.3950.54149558058956954694
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CashAndCashEquivalentsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueMeasurementsRecurring, us-gaap:MoneyMarketFunds


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value2202825904512307285105339.3950.54149558058956954694
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-31
Value353433678532429121126196748189566643659673651290173153
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CommercialPaperAtCarryingValue

us-gaap:CommercialPaperAtCarryingValue


Commercial
Period End2021-06-302021-03-31
Value2.69941
Percentage of CommercialPaperAtCarryingValue100.0100.0

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance us-gaap:SubsidiarySaleOfStock

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

us-gaap:EmployeeStock


Common
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value4.073.3372.6182.0241.6381.2851.6
Percentage of CommonStockCapitalSharesReservedForFutureIssuance100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerLiability


Contract
Period End2021-06-302021-03-312020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Value5.2563.6912.1470.03.4425453520.0
Percentage of ContractWithCustomerLiability100.0100.0100.00.0100.0100.0100.0100.00.0

us-gaap:ContractWithCustomerLiability us-gaap:ProductOrService

fgen:DrugProductRevenue


Contract
Period End2021-06-302020-12-31
Value305.984
Percentage of ContractWithCustomerLiability587.7278.7

us-gaap:Product


Contract
Period End2020-12-312020-09-302020-06-302019-12-31
Value151.6330.3891.102
Percentage of ContractWithCustomerLiability705.00.00.02.0

us-gaap:ContractWithCustomerLiability us-gaap:ProductOrService, us-gaap:BalanceSheetLocation, us-gaap:TypeOfArrangement

us-gaap:Product, fgen:ContractLiabilities, fgen:DirectSales


Contract
Period End2021-06-302021-03-312020-12-31
Value131515
Percentage of ContractWithCustomerLiability262.4432.9705.0

us-gaap:ContractWithCustomerLiability us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:ChinaPerformanceObligation, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value149142137141140141140137136127125119115
Percentage of ContractWithCustomerLiability2849.33869.26396.70.00.04098.8257.1254.4262.60.00.00.00.0

fgen:CoDevelopmentInformationSharingAndCommitteeServices, fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value2.3094.4492.2762.4354.5476.3238.452111616202932
Percentage of ContractWithCustomerLiability43.9120.5106.00.00.0183.715.421.031.40.00.00.00.0

fgen:DevelopmentAndOtherRevenue, country:JP, fgen:AstellasCollaborationAgreement


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value0.030.0750.130.1640.1830.2690.3750.3120.1360.2070.2860.386
Percentage of ContractWithCustomerLiability0.62.06.10.00.07.80.70.60.30.00.00.0

fgen:DevelopmentAndOtherRevenue, srt:Europe, fgen:AstellasCollaborationAgreement


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value0.3330.8251.4292.0962.3383.4424.793.9882.0192.3343.2254.35
Percentage of ContractWithCustomerLiability6.322.466.60.00.0100.08.77.43.90.00.00.0

fgen:DrugProductRevenue, country:JP, fgen:AstellasAgreement


Contract
Period End2021-06-30
Value1.974
Percentage of ContractWithCustomerLiability37.6

fgen:DrugProductRevenue, country:US, fgen:AstraZenecaAgreements


Contract
Period End2021-06-30
Value11
Percentage of ContractWithCustomerLiability212.5

fgen:DrugProductRevenue, srt:Europe, fgen:AstellasAgreement


Contract
Period End2021-06-302020-12-31
Value175.984
Percentage of ContractWithCustomerLiability337.6278.7

us-gaap:ContractWithCustomerLiability us-gaap:ProductOrService, us-gaap:TypeOfArrangement

fgen:DrugProductRevenue, fgen:AstellasCollaborationAgreement


Contract
Period End2021-03-312020-12-31
Value175.984
Percentage of ContractWithCustomerLiability480.7278.7

us-gaap:ContractWithCustomerLiability us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

fgen:Astellas, us-gaap:CollaborativeArrangement


Contract
Period End2021-06-302021-03-312020-12-312019-12-31
Value20187.50.4
Percentage of ContractWithCustomerLiability382.4503.9349.30.7

us-gaap:ContractWithCustomerLiability us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

country:CN, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value6.36.03.53.22.71.70.80.70.5
Percentage of ContractWithCustomerLiability119.9162.6163.00.00.049.41.51.31.0

country:JP, fgen:AstellasCollaborationAgreement


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value0.030.0750.130.1640.1830.2690.3750.3120.1360.2070.2860.3860.473
Percentage of ContractWithCustomerLiability0.62.06.10.00.07.80.70.60.30.00.00.00.0

fgen:UnitedStatesAndRestOfWorld, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-30
Value152147139149148152
Percentage of ContractWithCustomerLiability2893.83990.86502.1272.5275.2293.9

fgen:UnitedStatesRestOfWorldAndChina, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value152147139143145147149148152144146148148
Percentage of ContractWithCustomerLiability2893.23989.86502.70.00.04282.5272.5275.3294.00.00.00.00.0

srt:Europe, fgen:AstellasCollaborationAgreement


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value0.3330.8251.4292.0962.3383.4424.793.9882.0192.3343.2254.35
Percentage of ContractWithCustomerLiability6.322.466.60.00.0100.08.77.43.90.00.00.0

us-gaap:ContractWithCustomerLiability us-gaap:TypeOfArrangement

fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-31
Value149142137
Percentage of ContractWithCustomerLiability2849.33869.26396.7

us-gaap:ContractWithCustomerLiabilityNoncurrent

us-gaap:ContractWithCustomerLiabilityNoncurrent


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-31
Value1521511381371381399998102135136136137138
Percentage of ContractWithCustomerLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiabilityNoncurrent us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

fgen:UnitedStatesAndRestOfWorld, fgen:AstraZenecaAgreements


Contract
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-30
Value1461431379998102
Percentage of ContractWithCustomerLiabilityNoncurrent96.094.899.399.999.9100.0

us-gaap:ContractWithCustomerLiabilityNoncurrent us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType

srt:Europe, fgen:AstellasCollaborationAgreement, fgen:DrugProductRevenue


Contract
Period End2020-12-31
Value4.6
Percentage of ContractWithCustomerLiabilityNoncurrent3.3

us-gaap:ContractualObligation

us-gaap:ContractualObligation


Contractual
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value819386332623
Percentage of ContractualObligation100.0100.0100.0100.0100.0100.0

us-gaap:ContractualObligation us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

fgen:ManufactureAndSupplyOfPamrevlumab


Contractual
Period End2021-06-302021-03-31
Value4757
Percentage of ContractualObligation57.861.2

fgen:ManufactureAndSupplyOfRoxadustat


Contractual
Period End2021-06-302021-03-312020-09-302020-06-302020-03-31
Value2930161411
Percentage of ContractualObligation36.132.450.554.250.6

fgen:OtherPurchases


Contractual
Period End2021-06-302021-03-312020-09-302020-06-302020-03-31
Value5.06.05.51.10.6
Percentage of ContractualObligation6.16.416.64.22.6

us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent

us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent


Deferred
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-31
Value8985000.09025000.08675000.08637000.08653000.08786000.08913000.08138000.0
Percentage of DeferredTaxAndOtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory

us-gaap:DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory


Deferred
Period End2020-12-31
Value78
Percentage of DeferredTaxAssetIntraEntityTransferAssetOtherThanInventory100.0

us-gaap:DeferredTaxAssetsDeferredIncome

us-gaap:DeferredTaxAssetsDeferredIncome


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value1313161822103.304
Percentage of DeferredTaxAssetsDeferredIncome100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsGross


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value34222219315912911795
Percentage of DeferredTaxAssetsGross100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value134919171425344
Percentage of DeferredTaxAssetsOperatingLossCarryforwards100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards us-gaap:IncomeTaxAuthority

us-gaap:DomesticCountry


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value606404400306170185
Percentage of DeferredTaxAssetsOperatingLossCarryforwards452.7443.3436.6429.4396.5346.7

us-gaap:StateAndLocalJurisdiction


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value133129148143138270
Percentage of DeferredTaxAssetsOperatingLossCarryforwards99.7141.8161.5201.2322.1505.9

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value32372115118.4216.485
Percentage of DeferredTaxAssetsOperatingLossCarryforwardsForeign100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign us-gaap:IncomeTaxAuthority

us-gaap:ForeignCountry


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value17215286634835
Percentage of DeferredTaxAssetsOperatingLossCarryforwardsForeign533.4402.8405.3421.9412.7422.8

us-gaap:DeferredTaxAssetsTaxCreditCarryforwards

us-gaap:DeferredTaxAssetsTaxCreditCarryforwards


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value62524539292624
Percentage of DeferredTaxAssetsTaxCreditCarryforwards100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther us-gaap:IncomeTaxAuthority

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther

us-gaap:DomesticCountry


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value665446383127
Percentage of DeferredTaxAssetsTaxCreditCarryforwardsOther100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsOther us-gaap:StatementGeographical, us-gaap:IncomeTaxAuthority

stpr:CA, us-gaap:StateAndLocalJurisdiction


Deferred
Period End2020-12-312019-12-312018-12-31
Value322926
Percentage of DeferredTaxAssetsTaxCreditCarryforwardsOther49.254.356.7

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value10119.2817.835118.5125.836
Percentage of DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value5875000.05353000.06072000.04851000.05465000.04891000.05075000.0
Percentage of DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent

us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value8.243102.5112.7374.4144.3355.204
Percentage of DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent100.0100.0100.0100.0100.0100.0100.0

us-gaap:DueFromRelatedPartiesCurrent

us-gaap:DueFromRelatedPartiesCurrent


Due
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-06-302017-12-31
Value0.05.0150.8890.1650.01261251261270.0150.0
Percentage of DueFromRelatedPartiesCurrent0.0100.0100.0100.00.0100.0100.0100.0100.00.0100.00.0

us-gaap:DueFromRelatedPartiesNoncurrent

us-gaap:DueFromRelatedPartiesNoncurrent


Due
Period End2020-09-302019-12-31
Value1483000.00
Percentage of DueFromRelatedPartiesNoncurrent100.00.0

us-gaap:DueFromRelatedPartiesNoncurrent us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:Falikang


Due
Period End2020-09-30
Value1500000.0
Percentage of DueFromRelatedPartiesNoncurrent101.1

us-gaap:DueToRelatedPartiesCurrent

us-gaap:DueToRelatedPartiesCurrent


Due
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value0.0140.1210.0244.1350.2160.092360.9540.7810.5190.4440.3530.3270.5920.2720.4790.2690.2891.6151.8431.3511.6392.0453.5325.8174.5644.594
Percentage of DueToRelatedPartiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DueToRelatedPartiesCurrent us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:Astellas


Due
Period End2020-12-312019-12-31
Value1.136
Percentage of DueToRelatedPartiesCurrent4583.3100.0

us-gaap:DueToRelatedPartiesCurrent us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement

fgen:Astellas, us-gaap:CollaborativeArrangement


Due
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-12-31
Value0.11.14.10.20.1361.70.80.50.40.40.30.60.30.50.30.31.61.81.41.62.03.44.3
Percentage of DueToRelatedPartiesCurrent82.64583.399.292.6108.7100.0178.2102.496.390.1113.391.7101.4110.3104.4111.5103.899.197.7103.697.697.896.393.6

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EmployeeRelatedLiabilitiesCurrent


Employee
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value18152219141119171412211612111814109.051412109.51113119.6258.87615
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions us-gaap:AwardType

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions

us-gaap:RestrictedStockUnitsRSU


Employee
Period End2020-12-31
Value55
Percentage of EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions100.0

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions us-gaap:AwardType

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

fgen:StockOptionAwards


Employee
Period End2020-12-31
Value63
Percentage of EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions100.0

us-gaap:EquityMethodInvestments us-gaap:EquityMethodInvestmentNonconsolidatedInvestee

us-gaap:EquityMethodInvestments

fgen:BeijingFalikangPharmaceuticalCoLtd


Equity
Period End2021-06-302021-03-312020-12-31
Value3.0832.4832.728
Percentage of EquityMethodInvestments100.0100.0100.0

us-gaap:EquityMethodInvestments us-gaap:InvestmentsByConsolidatedAndNonconsolidatedEntities

fgen:BeijingFalikangPharmaceuticalCoLtd


Equity
Period End2020-09-30
Value10
Percentage of EquityMethodInvestments0.0

us-gaap:EquityMethodInvestments us-gaap:RelatedPartyTransactionsByRelatedParty

fgen:Falikang


Equity
Period End2021-06-302021-03-312020-12-312020-09-30
Value3.12.52.71.5
Percentage of EquityMethodInvestments100.6100.799.00.0

us-gaap:FinanceLeaseLiability

us-gaap:FinanceLeaseLiability


Finance
Period End2021-06-302021-03-312020-12-312020-09-302019-09-302019-06-302019-03-31
Value0.029343740525558
Percentage of FinanceLeaseLiability100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseLiability us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:AccountingStandardsUpdate201901, fgen:LeaseAmendment, fgen:ShorensteinPropertiesLLC


Finance
Period End2021-06-01
Value32
Percentage of FinanceLeaseLiability0.0

us-gaap:FinanceLeaseLiabilityCurrent

us-gaap:FinanceLeaseLiabilityCurrent


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value0.0231212121212121212110.0
Percentage of FinanceLeaseLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:FinanceLeaseLiabilityCurrent us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AccountingStandardsUpdate201901


Finance
Period End2021-06-30
Value12
Percentage of FinanceLeaseLiabilityCurrent54726.1

us-gaap:FinanceLeaseLiabilityNoncurrent

us-gaap:FinanceLeaseLiabilityNoncurrent


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-12-31
Value0.00622252831343740434697979797979797
Percentage of FinanceLeaseLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinanceLeaseLiabilityNoncurrent us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AccountingStandardsUpdate201901


Finance
Period End2021-06-30
Value20
Percentage of FinanceLeaseLiabilityNoncurrent333483.3

us-gaap:FinanceLeaseLiabilityPaymentsDue

us-gaap:FinanceLeaseLiabilityPaymentsDue


Finance
Period End2021-06-302021-03-312020-12-312020-09-30
Value0.03364043
Percentage of FinanceLeaseLiabilityPaymentsDue100.0100.0100.0100.0

us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths


Finance
Period End2021-06-302021-03-312020-12-312020-09-30
Value0.011131313
Percentage of FinanceLeaseLiabilityPaymentsDueNextTwelveMonths100.0100.0100.0100.0

us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree

us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree


Finance
Period End2020-12-312020-09-30
Value1212
Percentage of FinanceLeaseLiabilityPaymentsDueYearThree100.0100.0

us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo

us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo


Finance
Period End2021-06-302021-03-312020-12-312020-09-30
Value0.003121313
Percentage of FinanceLeaseLiabilityPaymentsDueYearTwo100.0100.0100.0100.0

us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear


Finance
Period End2021-06-302021-03-312020-09-30
Value0.016103.542
Percentage of FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear100.0100.0100.0

us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount

us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount


Finance
Period End2021-06-302021-03-312020-12-312020-09-30
Value1000.01997000.02380000.02807000.0
Percentage of FinanceLeaseLiabilityUndiscountedExcessAmount100.0100.0100.0100.0

us-gaap:FinanceLeaseRightOfUseAsset

us-gaap:FinanceLeaseRightOfUseAsset


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value0.8612729323437394244470.0
Percentage of FinanceLeaseRightOfUseAsset100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:FinanceLeaseRightOfUseAsset us-gaap:AdjustmentsForNewAccountingPronouncements

us-gaap:AccountingStandardsUpdate201901


Finance
Period End2021-06-30
Value24
Percentage of FinanceLeaseRightOfUseAsset2863.4

us-gaap:FinanceLeaseRightOfUseAsset us-gaap:AdjustmentsForNewAccountingPronouncements, us-gaap:LeaseContractualTerm, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:AccountingStandardsUpdate201901, fgen:LeaseAmendment, fgen:ShorensteinPropertiesLLC


Finance
Period End2021-06-01
Value24
Percentage of FinanceLeaseRightOfUseAsset0.0

us-gaap:FinanceLeaseRightOfUseAsset us-gaap:StatementGeographical

country:CN


Finance
Period End2020-12-312019-12-312018-12-31
Value0.0550.3650.0
Percentage of FinanceLeaseRightOfUseAsset0.20.90.0

country:US


Finance
Period End2020-12-312019-12-312018-12-31
Value29390.0
Percentage of FinanceLeaseRightOfUseAsset99.899.10.0

us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent

us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent


Finance
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value4.554.394.394.390.04390.04420.0442
Percentage of FinanceLeaseWeightedAverageDiscountRatePercent100.0100.0100.0100.0100.0100.0100.0

us-gaap:InterestPayableCurrentAndNoncurrent

us-gaap:InterestPayableCurrentAndNoncurrent


Interest
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value7100000.06200000.06000000.05900000.04900000.04800000.05000000.0
Percentage of InterestPayableCurrentAndNoncurrent100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryRawMaterials

us-gaap:InventoryRawMaterials


Inventory
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value1190000.03308000.02303000.01152000.0327000.0459000.0325000.0
Percentage of InventoryRawMaterials100.0100.0100.0100.0100.0100.0100.0

us-gaap:InventoryWorkInProcess

us-gaap:InventoryWorkInProcess


Inventory
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value159.6618.1145.6163.8152.9482.264
Percentage of InventoryWorkInProcess100.0100.0100.0100.0100.0100.0100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value151.6021.1420.714
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths100.0100.0100.0100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear


Lessee
Period End2021-06-302021-03-312020-09-30
Value7534000.01425000.0245000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear100.0100.0100.0

us-gaap:LiabilitiesFairValueDisclosure

us-gaap:LiabilitiesFairValueDisclosure


Liabilities
Period End2021-06-302021-03-312020-12-312014-12-31
Value0.91.01.197
Percentage of LiabilitiesFairValueDisclosure100.0100.0100.0100.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByLiabilityClass

us-gaap:FairValueInputsLevel3, fgen:LeaseObligations


Liabilities
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1.1411.2421.3431.4431.5441.6451.7451.84698
Percentage of LiabilitiesFairValueDisclosure103.70.00.00.00.00.00.00.00.0

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByLiabilityClass

fgen:LeaseObligations


Liabilities
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1.1411.2421.3431.4431.5441.6451.7451.84698
Percentage of LiabilitiesFairValueDisclosure103.70.00.00.00.00.00.00.00.0

us-gaap:MoneyMarketFundsAtCarryingValue

us-gaap:MoneyMarketFundsAtCarryingValue


Money
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
Value2202825904512307285105339.3950.54149558058956954685839410511344771041279.25513
Percentage of MoneyMarketFundsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value4.754.754.744.730.04730.04750.0475
Percentage of OperatingLeaseWeightedAverageDiscountRatePercent100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherSundryLiabilitiesNoncurrent

us-gaap:OtherSundryLiabilitiesNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312018-12-31
Value2469000.02661000.02690000.02186000.01787000.01357000.01340000.01855000.0
Percentage of OtherSundryLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PrepaidExpenseCurrent

us-gaap:PrepaidExpenseCurrent


Prepaid
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Value7149000.09602000.08353000.05549000.04429000.05267000.06464000.04051000.04716000.02705000.0
Percentage of PrepaidExpenseCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RecordedUnconditionalPurchaseObligation

us-gaap:RecordedUnconditionalPurchaseObligation


Recorded
Period End2020-12-31
Value86
Percentage of RecordedUnconditionalPurchaseObligation100.0

us-gaap:RecordedUnconditionalPurchaseObligation us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

fgen:ManufactureAndSupplyOfPamrevlumab


Recorded
Period End2020-12-31
Value57
Percentage of RecordedUnconditionalPurchaseObligation66.9

fgen:ManufactureAndSupplyOfRoxadustat


Recorded
Period End2020-12-31
Value25
Percentage of RecordedUnconditionalPurchaseObligation29.1

fgen:OtherPurchases


Recorded
Period End2020-12-31
Value3.418
Percentage of RecordedUnconditionalPurchaseObligation4.0

us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear

us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear


Recorded
Period End2020-12-31
Value44
Percentage of RecordedUnconditionalPurchaseObligationDueInSecondYear100.0

us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

fgen:ManufactureAndSupplyOfPamrevlumab


Recorded
Period End2020-12-31
Value33
Percentage of RecordedUnconditionalPurchaseObligationDueInSecondYear75.1

fgen:ManufactureAndSupplyOfRoxadustat


Recorded
Period End2020-12-31
Value10
Percentage of RecordedUnconditionalPurchaseObligationDueInSecondYear24.9

us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear

us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear


Recorded
Period End2020-12-31
Value42
Percentage of RecordedUnconditionalPurchaseObligationDueWithinOneYear100.0

us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchased

fgen:ManufactureAndSupplyOfPamrevlumab


Recorded
Period End2020-12-31
Value24
Percentage of RecordedUnconditionalPurchaseObligationDueWithinOneYear58.3

fgen:ManufactureAndSupplyOfRoxadustat


Recorded
Period End2020-12-31
Value14
Percentage of RecordedUnconditionalPurchaseObligationDueWithinOneYear33.6

fgen:OtherPurchases


Recorded
Period End2020-12-31
Value3.418
Percentage of RecordedUnconditionalPurchaseObligationDueWithinOneYear8.1

us-gaap:RelatedPartyTransactionDueFromToRelatedParty us-gaap:BalanceSheetLocation, us-gaap:RelatedPartyTransaction

us-gaap:RelatedPartyTransactionDueFromToRelatedParty

us-gaap:PrepaidExpensesAndOtherCurrentAssets, fgen:AstraZenecaAB


Related
Period End2020-09-30
Value9800000.0
Percentage of RelatedPartyTransactionDueFromToRelatedParty100.0

us-gaap:RevenueRemainingPerformanceObligation us-gaap:StatementGeographical, us-gaap:TypeOfArrangement

us-gaap:RevenueRemainingPerformanceObligation

srt:Europe, fgen:AstellasCollaborationAgreement


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value0.80.60.60.3128129129
Percentage of RevenueRemainingPerformanceObligation100.0100.0100.0100.0100.0100.0100.0

us-gaap:RevenueRemainingPerformanceObligation us-gaap:TypeOfArrangement

fgen:AstraZenecaAgreements


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value0.60.60.40.2424241
Percentage of RevenueRemainingPerformanceObligation75.0100.066.766.732.932.632.1

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value1893000.01483000.01428000.01562000.01211000.0865000.0560000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber us-gaap:AwardType

us-gaap:RestrictedStockUnitsRSU


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value1893000.01483000.01428000.01562000.01211000.0864850.0559580.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber100.0100.0100.0100.0100.0100.099.9

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

us-gaap:RestrictedStockUnitsRSU


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value37.649.0538.2624.7521.625.5818.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value7910000.07725000.06041000.04190000.04032000.03394000.05358000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber


Share
Period End2020-12-31
Value5576000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice


Share
Period End2020-12-31
Value29.5
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue


Share
Period End2020-12-31
Value86
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue


Share
Period End2020-12-31
Value84
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber


Share
Period End2020-12-31
Value8929000.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice


Share
Period End2020-12-31
Value32.76
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice100.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value66183248303141244
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1100.0100.0100.0100.0100.0100.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 us-gaap:PlanName

fgen:TwoThousandAndFourteenEquityIncentivePlan


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value89599711117486.50.3
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1133.832.239.336.912.719.90.00.0

us-gaap:Supplies

us-gaap:Supplies


Supplies
Period End2021-06-302021-03-312020-12-312020-06-302020-03-312019-12-312019-09-302019-06-302018-12-31
Value5.2567.7212.1470.01301801801800.0
Percentage of Supplies100.0100.0100.00.0100.0100.0100.0100.00.0

us-gaap:Supplies us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TransactionType

fgen:Astellas, fgen:APIShipment


Suppliesus-gaap:
Period End2021-03-31
Value4.0
Percentage of Supplies51.8

us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate


Unrecognized
Period End2020-12-31
Value500000.0
Percentage of UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate100.0

us-gaap:ValuationAllowancesAndReservesBalance us-gaap:ValuationAllowancesAndReservesType

us-gaap:ValuationAllowancesAndReservesBalance

fgen:ValuationAllowanceForRebatesAndDiscounts


Valuation
Period End2020-12-312019-12-31
Value0.5481.102
Percentage of ValuationAllowancesAndReservesBalance100.0100.0

us-gaap:ValuationAllowanceOfDeferredTaxAssets


Valuation
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value337213193159128116947370
Percentage of ValuationAllowancesAndReservesBalance61646.719405.40.00.00.00.00.00.00.0

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
('us-gaap:Product', 'country:CN', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('us-gaap:Product', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ValuationAllowancesAndReservesType
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:BalanceSheetLocation, us-gaap:ValuationAllowancesAndReservesType
(None, 'fgen:RebatesAndDiscounts')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Balance Sheet Location, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
(None, 'fgen:DrugProductRevenue')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', 'fgen:SalesToFalikang', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', 'fgen:DirectSales', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:PropertyPlantAndEquipmentNet
us-gaap:StatementGeographical
(None,)
Property Plant And Equipment Netus-gaap: Statement Geographical
us-gaap:OperatingLeaseRightOfUseAsset
us-gaap:StatementGeographical
(None,)
Operating Lease Right Of Use Assetus-gaap: Statement Geographical
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components